Exhibit 10.v
WHENEVER CONFIDENTIAL INFORMATION IS OMITTED HEREIN (SUCH OMISSIONS ARE DENOTED
BY AN ASTERISK), SUCH CONFIDENTIAL INFORMATION HAS BEEN SUBMITTED SEPARATELY TO
THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL
TREATMENT.
MEXICALI
DEVICE SUPPLY AND SERVICES AGREEMENT
AMONG:
ALPHA INDUSTRIES, INC.
A DELAWARE CORPORATION;
AND
CONEXANT SYSTEMS, INC.
A DELAWARE CORPORATION;
_________________________
DATED AS OF June 25, 2002
_________________________
TABLE OF CONTENTS
PAGE
1. DEFINITIONS ....................................................... 1
1.1 "ABC Costing Model" ........................................ 1
1.2 "Absorption" ............................................... 1
1.3 "Blanket Purchase Order" ................................... 1
1.4 "Buyer Spin-off" ........................................... 1
1.5 "Buyer Subsidiary".......................................... 1
1.6 "Common Material" .......................................... 1
1.7 "Common Material Savings" .................................. 2
1.8 "Competitor" ............................................... 2
1.9 "Confidential Information" ................................. 2
1.10 "Cycle Time" ............................................... 2
1.11 "Delivery Note" ............................................ 2
1.12 "Device" ................................................... 2
1.13 "Engineering Lots" or "e-Lots" ............................. 2
1.14 "Lead Time" ................................................ 2
1.15 "Lot" ...................................................... 2
1.16 "Manufacturing Services" ................................... 2
1.17 "Overall Factory Absorption" ............................... 2
1.18 "Party" .................................................... 2
1.19 "PBGA" ..................................................... 2
1.20 "Price" .................................................... 2
1.21 "Process Technology" ....................................... 3
1.22 "Production Devices" ....................................... 3
1.23 "Purchase Commitment" ...................................... 3
1.24 "Purchase Order" ........................................... 3
1.25 "Purchase Order Release" ................................... 3
1.26 "Quality Specifications" ................................... 3
1.27 "Risk Production" .......................................... 3
1.28 "Services" ................................................. 3
1.29 "Specifications" ........................................... 3
-i-
TABLE OF CONTENTS
(CONTINUED)
PAGE
1.30 "Supplier Manufacturing Facility" .......................... 3
1.31 "Unique Material" .......................................... 3
1.32 "Unique Material Savings" .................................. 3
2. PURCHASE AND SUPPLY OBLIGATIONS ................................... 3
2.1 Buyer Purchase Obligations ................................. 3
2.2 Supplier Supply Obligations ................................ 7
3. DEVICE PURCHASES .................................................. 9
3.1 Scope and Process Technologies ............................. 9
3.2 Forecasts and Commitments .................................. 10
3.3 Purchase Orders and Releases ............................... 10
3.4 Acceptance and Acknowledgement ............................. 10
3.5 Device Lots; Expedited Services ............................ 11
3.6 Cancellation and Modifications to Orders ................... 11
3.7 Materials .................................................. 12
3.8 Surge Capacity ............................................. 12
3.9 Risk Production ............................................ 12
3.10 Rework ..................................................... 13
3.11 NRE Services ............................................... 13
4. DELIVERY AND ACCEPTANCE OF DEVICES ................................ 13
4.1 Delivery Procedure ......................................... 13
4.2 Devices .................................................... 13
4.3 Device Logistics ........................................... 13
4.4 Shipping Arrangements ...................................... 13
5. PRICING AND PAYMENTS .............................................. 14
5.1 Pricing and Invoices ....................................... 14
5.2 Credit Requirements ........................................ 14
5.3 Costs ...................................................... 15
5.4 Taxes ...................................................... 15
6. TRACKING AND REPORTING ............................................ 15
6.1 Tracking ................................................... 15
-ii-
TABLE OF CONTENTS
(CONTINUED)
PAGE
6.2 Reporting Requirements ..................................... 15
6.3 Records and Audits ......................................... 15
7. WARRANTY AND DISCLAIMER ........................................... 16
7.1 Device Warranty ............................................ 16
7.2 Services Warranty .......................................... 16
7.3 Disclaimers ................................................ 16
8. INDEMNIFICATION ................................................... 17
8.1 Indemnification Obligations ................................ 17
8.2 Conditions ................................................. 17
8.3 Sole and Exclusive Remedy .................................. 18
9. CONFIDENTIALITY ................................................... 18
9.1 Confidentiality Obligations ................................ 18
9.2 Exceptions ................................................. 18
9.3 Confidentiality of this Mexicali Agreement ................. 19
9.4 Injunctive Relief .......................................... 19
10. LIMITATIONS OF LIABILITY .......................................... 19
10.1 Disclaimer ................................................. 19
10.2 Liability Limitation ....................................... 19
10.3 Basis of Bargain ........................................... 19
11. TERM AND TERMINATION .............................................. 19
11.1 Term ....................................................... 19
11.2 Termination ................................................ 19
11.3 Effect of Termination ...................................... 20
11.4 Termination of Buyer Spin-off Agreements ................... 20
12. GENERAL ........................................................... 21
12.1 No Agency .................................................. 21
12.2 Governing Law; Venue and Jurisdiction ...................... 21
12.3 Dispute Resolution and Escalation .......................... 21
12.4 Third-Party Beneficiaries .................................. 22
12.5 Compliance with Law ........................................ 22
-iii-
TABLE OF CONTENTS
(CONTINUED)
PAGE
12.6 Force Majeure .............................................. 22
12.7 Amendment; Later Agreement ................................. 22
12.8 Notices .................................................... 22
12.9 Assignment ................................................. 23
12.10 Waiver ..................................................... 23
12.11 Severability ............................................... 23
12.12 Counterparts and Facsimile ................................. 23
12.13 Rules of Construction ...................................... 23
12.14 Entire Agreement ........................................... 24
EXHIBIT A - CYCLE TIMES ................................................ 26
EXHIBIT B - PRICING .................................................... 27
EXHIBIT C - MANUFACTURING SERVICES ..................................... 43
EXHIBIT D - QUALITY SPECIFICATIONS ..................................... 44
EXHIBIT E - PURCHASE COMMITMENTS ....................................... 45
EXHIBIT F - ASSEMBLY, TEST AND SHIPPING QUARTERLY RATES ................ 46
EXHIBIT G - TAKE OR PAY ACTIVITY ....................................... 47
EXHIBIT H - [BLANK] .................................................... 48
EXHIBIT I - DELIVERY AND LOGISTICS ..................................... 49
EXHIBIT J - REPORTS .................................................... 50
EXHIBIT K - RECONCILIATION TABLE ....................................... 51
-iv-
MEXICALI
DEVICE SUPPLY AND SERVICES AGREEMENT
This MEXICALI DEVICE SUPPLY AND SERVICES AGREEMENT (the "MEXICALI AGREEMENT") is
entered into as of June 25, 2002 (the "EFFECTIVE DATE") by and between CONEXANT
SYSTEMS, INC., a Delaware corporation ("BUYER") and ALPHA INDUSTRIES, INC., a
Delaware corporation ("SUPPLIER").
RECITALS
A. Buyer desires, on the terms and conditions of this Mexicali
Agreement, to purchase from Supplier certain semiconductor devices, processing,
packaging and testing services, including assembly services, final testing,
post-test processing and die bank and finished goods warehousing and shipping
services, and related manufacturing services.
B. Supplier is willing to supply such devices and services to Buyer
on the terms and conditions of this Mexicali Agreement.
NOW, THEREFORE, in consideration of the mutual covenants and agreements
contained in this Mexicali Agreement, the Parties agree as follows:
AGREEMENT
1. DEFINITIONS. Capitalized terms not expressly defined elsewhere in this
Mexicali Agreement have the following meanings:
1.1 "ABC COSTING MODEL" means an Excel based model to determine
manufacturing overhead costs using Activity Based Costing methodology. The model
takes manufacturing overhead costs and assigns them to each of the manufacturing
operations through predefined allocation tables. Once the overhead cost to run
each process is determined, a rate per hour for every process is calculated
using activity and capacity standards.
1.2 "ABSORPTION" means the total amount earned by taking the unit
standards multiplied by the per unit cost.
1.3 "BLANKET PURCHASE ORDER" means a written blanket order for the
purchase of a specified quantity of Devices or Manufacturing Services submitted
by Buyer to Supplier.
1.4 "BUYER SPIN-OFF" means any entity (including, without limitation,
Mindspeed) that is a successor of any portion of the business of Buyer resulting
from a spin-off or divestiture of such business, regardless of whether or not
Buyer retains an equity or ownership interest in such entity.
1.5 "BUYER SUBSIDIARY" means any entity that at any time during the
term of this Mexicali Agreement controls, is controlled by, or is under common
control with Buyer; where control means direct or indirect ownership of fifty
percent (50%) or more of the outstanding voting stock or other equity interests
ordinarily having voting rights.
1.6 "COMMON MATERIAL" means materials used in the processing,
packaging and testing of Devices for Buyer and for devices of Supplier or its
other customers.
1.
1.7 "COMMON MATERIAL SAVINGS" means savings relating to the purchase
of Common Material computed as described in Section 5.l(e).
1.8 "COMPETITOR" means a business entity which derives a material
portion of its revenue (over the most recent three (3) year period) from sales
of similar products in similar markets, as compared with the products and
markets of a Party.
1.9 "CONFIDENTIAL INFORMATION" means (i) for information disclosed
after the Effective Date, all non-public information disclosed by one Party to
the other Party pursuant to this Mexicali Agreement that is identified as
"confidential" or marked with a similar legend at the time of such disclosure
or, if disclosed other than in writing, identified as confidential at the time
of disclosure and confirmed in writing within thirty (30) days, (ii) for
information currently in the possession of the other Party as of the Effective
Date, all non-public information that a reasonable person would have understood
to be confidential, regardless of the form or manner of disclosure, (iii) any
information obtained by one Party's employees or agents while on the premises of
the other Party, which, under the circumstances, a reasonable person would have
understood to be confidential, and (iv) any specifications or technical
information related to Buyer's products (e.g., structure, design, layout) and
Supplier's Process Technology that are known to, or otherwise in the possession
of, the other Party as of the Effective Date.
1.10 "CYCLE TIME" means, with respect to a Device, Supplier's standard
production cycle measured from start of Device manufactured through finished
goods inventory and set forth in Exhibit A.
1.11 "DELIVERY NOTE" means the delivery instructions provided by Buyer
to Supplier for Services and Devices ordered by Buyer.
1.12 "DEVICE" means a packaged and tested integrated circuit.
1.13 "ENGINEERING LOTS" or "E-LOTS" means a non-production Lot for
process of Device qualification or testing.
1.14 "LEAD TIME" means, with respect to a Device, the time period from
order acceptance to completion.
1.15 "LOT" means a group of Devices processed together through the
manufacturing line.
1.16 "MANUFACTURING SERVICES" means the performance of all tasks and
responsibilities necessary to complete assembly, test processes, final packing,
and other services described in this Mexicali Agreement, as further set forth in
Exhibit C.
1.17 "OVERALL FACTORY ABSORPTION" means the total activity at the
Supplier Manufacturing Facility multiplied by the quarterly rates set forth in
Exhibit F.
1.18 "PARTY" means either Buyer or Supplier, as the context requires,
and "PARTIES" means Buyer and Supplier collectively.
1.19 "PBGA" means plastic ball grid array devices.
1.20 "PRICE" is defined in Exhibit B.
-2-
1.21 "PROCESS TECHNOLOGY" means the systematic techniques, methods, or
approaches used by Supplier to complete assembly, test processes and final
packing of semiconductor chips or assemblies.
1.22 "PRODUCTION DEVICES" means Devices manufactured by Supplier after
successful qualification and approval for mass production.
1.23 "PURCHASE COMMITMENT" is defined in Section 2.1(a).
1.24 "PURCHASE ORDER" means a written Purchase Order Release under a
Blanket Purchase Order, or a Purchase Order for the purchase of a specified
quantity of Devices or Manufacturing Services submitted by Buyer to Supplier.
1.25 "PURCHASE ORDER RELEASE" means a written release issued by Buyer
authorizing Supplier to commence processing of the Devices under a Blanket
Purchase Order.
1.26 "QUALITY SPECIFICATIONS" means the Device quality standards and
criteria set forth in Exhibit D, as they may be modified by written agreement of
the Parties from time to time.
1.27 "RISK PRODUCTION" means Devices specifically identified by Buyer
in a Purchase Order as "Risk Production" that are to be manufactured by Supplier
pursuant to Buyer's Specifications, but for which compliance with the Quality
Specifications is specifically waived. "Risk Production" may include the
following: unverified process changes, no supporting qualification date, and
known design rule violations.
1.28 "SERVICES" means Manufacturing Services, test engineering
services, or such other services described in this Mexicali Agreement, as
applicable.
1.29 "SPECIFICATIONS" means the technical specifications for the
Devices mutually agreed to in writing by the Parties for such Devices, as they
may be modified from time to time upon written agreement of the Parties.
1.30 "SUPPLIER MANUFACTURING FACILITY" means the Device assembly, test
processes, and final packing facility or facilities owned or operated by
Supplier.
1.31 "UNIQUE MATERIAL" means material used only in the processing,
packaging, and testing of Devices for Buyer and not used for devices of Supplier
or its other customers.
1.32 "UNIQUE MATERIAL SAVINGS" means savings relating to the purchase
of Unique Material.
2. PURCHASE AND SUPPLY OBLIGATIONS.
2.1 BUYER PURCHASE OBLIGATIONS.
(a) PURCHASE COMMITMENTS. After the Effective Date and subject
to the terms and conditions of this Mexicali Agreement, Buyer will submit
Purchase Orders to Supplier for manufacture of Devices and providing of Services
in volumes sufficient to meet the commitments set forth in Exhibit E (the
"PURCHASE COMMITMENTS"). The Purchase Commitments shall be equal to the total
dollars spent per quarter based on the quarterly rates set forth in Exhibit F
and the activity set forth in Exhibit G. If Buyer does not submit Purchase
Orders sufficient to meet the Purchase Commitments, Buyer shall pay to Supplier,
as Supplier's sole remedy, the amount described in Section 2.1(b).
-3-
(b) RECONCILIATION PROCESS. After the close of each fiscal
quarter, the Parties shall participate in the reconciliation process described
in this Section 2.l(b). Actual activity will be represented by the number of
Devices and Services for which Purchase Orders were submitted by Buyer
(including Purchase Order Releases from prior quarters whose delivery dates have
been rescheduled into the fiscal quarter, and deducting any Purchase Order
Releases which have been cancelled or whose delivery has been rescheduled, by
Buyer, outside of the fiscal quarter). The "BUYER'S ABSORPTION" will be
calculated at the end of each fiscal quarter, which for the purpose of this
Section shall be defined as actual activity multiplied by the planned quarterly
rates set forth in Exhibit F. The Buyer's Absorption will be compared with the
planned absorption for the quarter as set forth in Exhibit E. At the close of
each fiscal quarter, the actual spending and activity levels will be entered
into the ABC Costing Model in effect as of the Effective Date. The depreciation
(computed without regard to any asset write-downs after the Effective Date) and
headcount allocations within the model will be updated on a quarterly basis, as
mutually agreed to by the Parties. The ABC Costing Model will be used to
calculate the actual rates for the quarter that just closed.
(i) SCENARIOS. Please see reconciliation table in Exhibit
K for further clarification of the reconciliation process.
(1) If the Buyer's Absorption remains flat to the
specific quarterly plan set forth in Exhibit E and the Overall Factory
Absorption has increased from the specific quarterly plan, then the resulting
quarterly actual rates will be used. The determined total cost charged to Buyer
will be the actual activity multiplied by the actual rates.
Example: As shown in Exhibit E, Buyer's planned absorption for Q4-02 is
$11.9M. The planned total factory absorption for Q4-02 is $23.3M. If the
Buyer's Absorption based on the actual activity and Q4-02 planned rates
is $11.9M and the Overall Factory Absorption based on Q4-02 rates is
$24.0M, the actual activity and actual ABC rates will be used to
determine Buyer's charge for the quarter.
(2) If the Buyer's Absorption remains flat to the
quarterly plan, and the Overall Factory Absorption has remained flat or
decreased to the specific quarterly plan, then the determined total charge to
Buyer will be the take or pay amount planned for that specific quarter as
further described in Exhibit E.
Example: As shown in Exhibit E, Buyer's planned absorption for Q4-02 is
$11.9M. The planned total factory absorption for Q4-02 is $23.3M. If the
Buyer's Absorption based on the actual activity and Q4-02 planned rates
is $11.9M and the Overall Factory Absorption based on Q4-02 rates is
$22.0M, Buyer will be charged based on the actual activity times the
planned rates for Q4-02. The charge will be the take or pay amount.
(3) If Buyer's Absorption has decreased from the
quarterly plan, and the Overall Factory Absorption has remained flat or
decreased to the specific quarterly plan, then the determined total charge to
the Buyer will be the take or pay amount.
Example: As shown in Exhibit E, Buyer's planned absorption for Q4-02 is
$11.9M. The planned total factory absorption for Q4-02 is $23.3M. If the
Buyer's Absorption based on the actual activity and Q4-02 planned rates
is $10.0M and the Overall Factory Absorption based on Q4-02 rates is
$22.0M, Buyer will be charged based on the actual activity times the
planned rates for Q4-02. The charge will be the take or pay amount.
-4-
(4) If Buyer's Absorption has decreased from the
quarterly plan and the Overall Factory Absorption has increased from the
specific quarterly plan, the determined total charge to the Buyer will be the
total actual cost when using actual activity and actual rates.
Example: As shown in Exhibit E, Buyer's planned absorption for Q4-02 is
$11.9M. The planned total factory absorption for Q4-02 is $23.3M. If the
Buyer's Absorption based on the actual activity and Q4-02 planned rates
is $10.0M and the Overall Factory Absorption based on Q4-02 rates is
$24.0M, the actual activity and actual ABC rates will be used to
determine Buyer charge for the quarter.
(5) If Buyer's Absorption has increased from the
quarterly plan, and the Overall Factory Absorption has increased from the
specific quarterly plan. The determined total cost charged to the buyer will be
the actual activity multiplied by the actual rates.
Example: As shown in Exhibit E, Buyer's planned absorption for Q4-02 is
$11.9M. The planned total factory absorption for Q4-02 is $23.3M. If the
Buyer's Absorption based on the actual activity and Q4-02 planned rates
is $12.0M and the Overall Factory Absorption based on Q4-02 rates is
$26.0M, the actual activity and actual ABC rates will be used to
determine Buyer charge for the quarter.
(6) If Buyer's Absorption has increased from the
quarterly plan, and the Overall Factory Absorption has remained flat or
decreased from the specific quarterly plan. The determined total cost charged to
the buyer will the actual activity multiplied by the quarterly planned rates.
Example: As shown in Exhibit E, Buyer's planned absorption for Q4-02 is
$11.9M. The planned total factory absorption for Q4-02 is $23.3M. If the
Buyer's Absorption based on the actual activity and Q4-02 planned rates
is $12.0M and the Overall Factory Absorption based on Q4-02 rates is
$23.0M, Buyer will be charged based on the actual activity times the
planned rates for Q4-02.
(ii) CREDIT OR DEBIT TO BUYER'S ACCOUNT. The credit or
debit to Buyer's account is calculated by taking the determined total charge to
the Buyer and subtracting what the Buyer has already been invoiced for during
the quarter, pursuant to Section 5.l(a), based on the actual activity and
Purchase Order prices. If the determined total charge is less than the invoiced
amount, the difference is credited to Buyer's account. If the determined total
charge is greater than the invoiced amount, the difference is charged to Buyer's
account for payment in accordance with Section 5.
(iii) QUALITY REQUIREMENTS.
(1) Products manufactured at the Supplier
Manufacturing Facility shall meet or exceed normal, accepted standards of
quality in the industry. For the purpose of this Agreement, these standards
shall include visual, mechanical, thermal and electrical specifications that
comply with released drawings and specifications, any changes to which must be
mutually agreed upon by the Parties. The products manufactured shall pass normal
"qualification" testing consistent with current practices as of the Effective
Date (as may be modified by the Parties from time to time), such as HAST, Temp
Cycling, Moisture Sensitivity, and HTOL. Packaging, die attach and wire bonding
attributes such as pull strength, die shear, ball shear test, and 3rd optical
yield, must be in statistical control and the limits will be jointly agreed upon
by the Parties. A higher yield loss than Normal Yield loss (assembly yield) will
also be considered a quality issue.
-5-
(2) The Parties agree that the "NORMAL YIELD"
shall be defined as the "standard yield" for each Device or Package type in use
by the Supplier on the Effective Date. For any yield less than 90% of the Normal
Yield Buyer shall be relieved of its Purchase Commitments for that portion of
the loss that is below the Normal Yield and, if Buyer determines in its
reasonable discretion that the entire WIP of the affected devices should be put
on hold and obtained from an alternative source, pending resolution of the
quality problem, Buyer shall confer with Supplier regarding the yield issue and
shall be relieved of its Purchase Commitment for the entire WIP of the affected
Devices. In the event of any yield loss exceeding the Normal Yield loss, the
Parties agree to cooperate in good faith in order to reduce the yield loss and
to resume the Purchase Commitments contemplated by this Agreement as soon as
yield returns to Normal Yield. Notwithstanding the foregoing, Buyer shall not be
relieved of its Purchase Commitments for any unrecoverable assembly yields where
such assemblies are not designed in accordance with Supplier's released design
rules associated with the manufacturability and mutually agreed to by the
Parties or fail as a result of materials incorporated in the Device (except for
PBGAs, which are specifically excluded from this Section). The Parties
acknowledge and agree that all Devices and packaging types provided as of the
Effective Date shall be deemed to comply with all required design rules.
(iv) DIE CONSTRAINTS. Supplier's inability to provide
Devices arising from the unavailability of die or other materials which are to
be provided by Buyer shall not be considered a Supplier failure hereunder. Buyer
will not be relieved of its Purchase Commitment liability on account of such die
or other materials capacity constraints.
(c) CREDITS; BUYER RAW MATERIAL BUY BACK. As of the Effective
Date, all of Buyer's Unique Material, fifty percent (50%) of the Common
Material, and all Buyer work-in-process ("WIP") will transfer to Supplier at
"NET VALUE" defined as the gross inventory value plus any Financial Reserves on
Unique Material. For purposes of this Section 2.1(c)(i), "FINANCIAL RESERVES"
means a financial adjustment to properly state inventory value that brings the
gross value to the net book value. Excess inventory is reserved if there is
inventory above the six (6) month demand. Buyer will receive full credit for the
Net Value of the Unique Materials, Common Materials and WIP, in the form of six
(6) monthly credits from Supplier, such that Buyer has recovered the full Net
Value of such materials during the first six (6) months from the Effective Date.
All Unique Material that is reserved material will be identified by part and
quantity; Common Materials and WIP do not have reserves. Six (6) months from the
Effective Date, Supplier will determine the remaining Unique Material reserved
inventory on a part by part basis and all remaining reserved material inventory
will be deemed "INACTIVE MATERIAL." Inactive Material will be dispensed with the
manner prescribed in Section 5.1(b)(ii). Relative to such application of Section
5.1 under this Section 2.l(c)(i), the Parties agree that the "cost" for such
purposes will be the transfer cost of such Inactive Material reserved inventory
as described in this Section (e.g., if the material is transferred to Supplier
at zero (0) "Net Value", then Supplier's "cost" would be $0.00). Reserved
inventory used by Supplier by the sixth (6th) month determination will be
credited to Buyer after the seventh (7th) month from the Effective Date.
(d) PURCHASES FOR CERTAIN ENTITIES. Supplier agrees that Buyer,
as agent, may, at any time at the prices and in accordance with the terms and
conditions established under this Mexicali Agreement, place orders for Devices
and Services on behalf of (i) third parties that are mutually agreed to by the
Parties; (ii) Buyer Subsidiaries; (iii) Buyer Spins-Offs (excluding
SpecialtySemi); and (iv) third parties for which Buyer has an obligation,
existing as of the Effective Date, to provide Devices and Services.
Notwithstanding the foregoing and for the avoidance of doubt, Supplier hereby
acknowledges and agrees that Buyer may, at any time at the prices and in
accordance with the terms and conditions of this Mexicali Agreement, place
orders for Devices or Services on behalf of Rockwell, SiRF, Mindspeed and
Lumero. If Buyer places an order on behalf of a third party, Supplier will, at
Buyer's direction, ship
-6-
products ordered on behalf of such third party directly to such third party's
facilities, as applicable. Supplier may invoice Buyer or such third party for
such orders, it being understood that the applicable third party may pay the
invoiced amount directly to Supplier, however, Buyer, as agent for such third
party, shall remain jointly and severally liable for any such payments due to
Supplier. Notwithstanding the foregoing, however, if any such third party is
reasonably determined to be a Competitor of Supplier or its affiliates, Supplier
may, upon six (6) months written notice to Buyer, refuse to fulfill orders for
such third party; provided that Supplier will continue to manufacture, supply
and provide to Buyer, in accordance with the Device and Service purchase
procedures in Section 3, any Devices or Services ordered for such third party
for delivery prior to the expiration of such six (6) month period.
(e) BUYER SPIN-OFFS. The Parties acknowledge and agree that each
Buyer Spin-off will have the right to enter into a supply agreement with
Supplier on terms and conditions substantially similar to the terms and
conditions set forth in this Mexicali Agreement and Supplier agrees to enter
into such agreement upon Buyer Spin-offs request. Such Buyer Spin-offs purchases
are subject to the Buyer Spin-off credit requirements set forth in Section 5.2.
Buyer may partition the Purchase Commitments between Buyer and such Buyer
Spin-offs. If Buyer and Buyer Spin-off partition the Purchase Commitments, the
determination of whether the Purchase Commitments are met will be determined on
a collective basis, and no additional payments to meet the Purchase Commitments
will be due to Supplier if the total purchases by Buyer and the Buyer Spin-offs
meets or exceeds the applicable Purchase Commitment.
(f) ADDITIONAL PURCHASE NEEDS. Subject to Buyer's obligations to
third parties existing as of the Effective Date, Buyer shall submit all of
Buyer's requirements for leadframe Devices and test Services in excess of the
Purchase Commitment to Supplier, provided that: (i) the current leadframe
Devices and package type are both qualified to be manufactured at the Supplier
Manufacturing Facility, or for new leadframe Devices, the package type is
qualified to be manufactured at the Supplier Manufacturing Facility; (ii)
Supplier has sufficient uncommitted available capacity; (iii) Supplier's
committed delivery dates are competitive with other suppliers; (iv) Supplier has
the necessary testers available; and (v) Supplier offers competitive pricing for
such leadframe Devices and test Services. If such additional requirements are
outside of the normal forecasting process as identified in Section 3.2, Supplier
shall have the first right of refusal to accept Buyer's orders to provide such
leadframe Devices and test Services and shall have one (I) business day to
accept and acknowledge Buyer's Purchase Orders for such leadframe Devices and
test Services. If the additional requirement is identified in the normal
forecasting process outlined in Section 3.2, Supplier shall have three (3)
business days to accept and acknowledge Buyer's Purchase Order. If a customer
requires that Buyer have a second source of supply for such leadframe Devices
and/or test Services, Buyer may establish and purchase from such second source,
and the Parties shall discuss the allocation of purchase requirements between
Supplier and such alternate source based on pricing, available capacity at the
Supplier Manufacturing Facility, and second source requirements; provided, that
in no event, shall Supplier's allocation be zero. If Supplier does not respond
to Buyer's Purchase Order within the required time of receipt, or cannot meet
the other requirements set forth in this Section 2.l(f), Buyer may purchase such
leadframe Devices and test Services from any other party in quantities necessary
to obtain the required leadframe Devices or Services.
2.2 SUPPLIER SUPPLY OBLIGATIONS.
(a) SUPPLY OBLIGATIONS. During the term of the Mexicali
Agreement, Supplier will provide Buyer with certain Manufacturing Services and
other semiconductor processing and packaging Services. Supplier shall accept all
Purchase Orders and fulfill and provide capacity for each Service and Device in
the volumes indicated in the Purchase Commitment up to the capacity identified
in Exhibit G.
-7-
Performance of such obligations by Supplier shall be in accordance with the
Specifications, Quality Specifications, and performance metrics including
quality, yield, and Cycle Time, that are consistent with established industry
standards. Supplier will make commercially reasonable efforts to supply capacity
requirements beyond the Purchase Commitment for each Service and Device
(b) MANUFACTURING PROCEDURES. The Devices will be manufactured
and produced using the Quality Agreement Document, Specification Number
GNO3-1306 as a nonbinding guideline. Both parties are committed to actively
achieving the requirements outlined in this document. Modifications to such
document shall require the consent of Supplier, which consent shall not be
unreasonably withheld or delayed. Appropriate adjustments to pricing shall be
made for any changes which modify Device costs.
(c) NOTICE REQUIREMENTS. If at any time Supplier believes or
becomes aware that it is likely to fail to comply in a material manner with its
supply obligations under this Mexicali Agreement, or if Supplier believes or
becomes aware that Buyer's forecasts or Purchase Orders for Devices or Services
covered by this Mexicali Agreement, when taken in the aggregate, will exceed the
maximum capacity or capability of the installed available capacity of the
Supplier, then Supplier will promptly notify Buyer in writing. (However, without
reduction of this commitment, Supplier shall have no monetary liability for its
failure to do so.) In addition, Supplier shall, on a quarterly basis, provide
Buyer with an assessment of known and existing capacity issues of the Supplier,
and any capacity issues anticipated over the next fifteen (15) month period, and
the plan to remedy such issues.
(d) DISCONTINUANCE OF MANUFACTURING PROCESS. Subject to the
restrictions in this Section 2.2(d), Supplier may terminate the use of any
Manufacturing Services at the Supplier Manufacturing Facility designated as an
"END-OF-LIFE PROCESS" or a "last-time-build" package type. At least eighteen
(18) months prior to the date the discontinuance of such process or package
manufacturing will commence, Supplier shall provide Buyer with written notice of
its intent to terminate such Manufacturing Service. Buyer may identify a
suitably qualified alternative supplier (the "FOLLOW-ON SUPPLIER"), which
selection shall be subject to Supplier's approval (which shall not be
unreasonably withheld or delayed). Upon selection of a qualified alternative
supplier, Supplier shall prepare a transition plan specifically designed to
ensure that there is minimal interruption in Buyer's supply of Manufacturing
Services arising in the transfer of production to the Follow-On Supplier and
obtain Buyer's written approval of such transition plan (which shall not be
unreasonably withheld or delayed); however, failure to obtain Buyer's written
approval shall not serve as grounds to extend the eighteen (18) month notice
described in this Section 2.2(d). Supplier will at Buyer's expense, pre-approved
by Buyer (which shall not be unreasonably withheld or delayed), work with Buyer
to perform the transition in accordance with the Buyer-approved plan and will
take commercially reasonable steps to ensure a smooth transition. In addition,
Buyer will have the right, until the expiration of eighteen (18) months from the
date of Supplier's notice of discontinuance, to submit Purchase Orders for
packages to be manufactured, or tested with such Manufacturing Services within
such eighteen (18) month period. Buyer acknowledges that all such Purchase
Orders placed during months seven (7) to eighteen (18) of the eighteen (18)
month notice period for Manufacturing Services processed with an
End-of-Life-Process (i) are non-cancelable and except for non conforming Devices
are non-returnable, and (ii) unless mutually agreed otherwise, such Purchase
Orders will not exceed the total quantity of such Manufacturing Services or
Devices manufactured, packaged, or tested with such End-of-Life Process ordered
during the eighteen (18) month period immediately prior to the end-of-life
notice provided under this section. The foregoing obligations are in addition to
Supplier's other obligations under this Mexicali Agreement.
(e) CLOSING OF SUPPLIER MANUFACTURING FACILITY. Supplier shall
notify Buyer at least eighteen (18) months prior to the date that Supplier
intends to commence any closure, in whole or in
-8-
part, of the Supplier Manufacturing Facility. If Buyer elects to do so, Buyer
may identify a suitably qualified alternative supplier of Manufacturing Services
(the "FOLLOW-ON SUPPLIER"), and subject to Supplier's approval (which shall not
be unreasonably withheld or delayed). Supplier shall prepare a transition plan
specifically designed to ensure that there is minimal interruption in Buyer's
supply of Manufacturing Services arising in the transfer to the Follow-On
Supplier and obtain Buyer's written approval of such transition plan (which
shall not be unreasonably withheld or delayed); however failure to obtain
Buyer's written approval shall not serve as grounds to extend the eighteen (18)
month notice described in this Section 2.2(e). Supplier will seek to perform the
transfer of Manufacturing Services in accordance with the Buyer-approved plan
and will at Buyer's expense take all commercially reasonable steps to ensure a
smooth transition of the Manufacturing Services. Buyer shall reimburse Supplier
for Supplier's reasonable direct and indirect expenses incurred by Supplier, and
pre-approved by Buyer, in transitioning such technology to the designated
facility. Buyer will have the right, until the expiration of such eighteen (18)
month period, to continue to submit Purchase Orders for Devices and Services to
Supplier for delivery within such eighteen (18) month period. Supplier will
continue to manufacture, supply, and provide to Buyer, in accordance with the
purchase procedures in Section 3, any such Devices and Services that are
ordered. Buyer acknowledges that all such Purchase Orders placed during months
seven (7) to eighteen (18) of the eighteen (18) month notice period for Devices
or Services (i) are non-cancelable and except for non-conforming products are
non-returnable and (ii) unless mutually agreed otherwise, will not exceed the
total quantity of such Manufacturing Services or Devices manufactured, packaged,
or tested with such End-of-Life Process ordered during the eighteen (18) month
period immediately prior to the end-of-life notice provided under this section.
The foregoing obligations are in addition to Supplier's other obligations under
this Mexicali Agreement.
(f) SUPPLY INTERRUPTIONS. If at any time Supplier fails for any
reason (including, without limitation, force majeure events, discontinuance of
manufacturing process or closing of the Supplier Manufacturing Facility) to
fulfill its supply obligations under this Mexicali Agreement, Buyer's obligation
under Section 2.l(a) shall be reduced, for the period of supply interruption, by
the volumes Supplier failed to supply, or the minimum quantity of Devices or
Services Supplier is required to obtain from alternate source(s), whichever is
greater. This Section 2.2(f) shall not limit any other rights or remedies Buyer
may have for a breach of this Mexicali Agreement or otherwise.
(g) PBGA SUPPLY OBLIGATIONS. Supplier agrees to use reasonable
commercial efforts to support Buyer's requirements for PBGA Device assembly and
subsequent testing, that are currently qualified and sole sourced as of the
Effective Date, as per a rolling four (4) month forecast. Supplier agrees to
provide these PBGA services at the pricing as established per the ABC Costing
Model, and without warranties. Supplier shall manufacture such PBGAs for a
minimum of twenty four (24) months from the Effective Date, subject to the
provisions of Sections 2.2(d) and (e). PBGAs purchased under this Agreement
shall not be counted toward Buyer's Purchase Commitment. All other terms and
conditions shall be as mutually agreed.
3. DEVICE PURCHASES.
3.1 SCOPE AND PROCESS TECHNOLOGIES.
(a) DEVELOPED AND QUALIFIED. Upon receipt of an applicable
Purchase Order, Supplier shall provide management, planning, and procurement of
Devices and Services for Buyer. Buyer will have the right to purchase Devices
and Services in production, or released to production, at the Supplier
Manufacturing Facility as of the Effective Date pursuant to the terms and
conditions of this Mexicali Agreement including Exhibit G.
-9-
(b) NEW OR NON-STANDARD PROCESS TECHNOLOGIES. Unless otherwise
mutually agreed to by the Parties, Supplier shall have no obligation to provide
Devices and Services manufactured or provided through the use of any new or
non-standard Process Technologies.
3.2 FORECASTS AND COMMITMENTS.
(a) On or about the last day of each calendar month during the
term of this Mexicali Agreement, Buyer will provide to Supplier a rolling
non-binding forecast, covering a minimum period of fifteen (15) months. Buyer's
forecasts are for planning purposes only and will not bind Buyer in any respect.
Before the end of each week, Buyer will provide an updated thirteen (13) week
forecast. The first three (3) weeks (nearest the current date) are considered
and will reflect firm orders. Week 1 (nearest the current date) will reflect a
current week of work in process and Weeks two (2) and three (3) will reflect two
(2) frozen weeks of committed assembly outs and test outs. Each such forecast
will include, as applicable: (i) assembly outs by package type and (ii) test
outs by tester platform. Except as otherwise specifically set forth in Section
2.1(a), only a written Purchase Order delivered in accordance with Section 3.3
will bind Buyer to purchase specified volumes of Devices or Services. Buyer
agrees to place Purchase Orders sufficient to commit and bind the committed
portions of the forecast described in this Section 3.2(a). Purchase Orders will
accurately reflect the first three (3) weeks of the thirteen (13) week forecast
and will be approved by an authorized representative of Buyer.
(b) Except as to Weeks 1, 2, and 3 (as described above), Buyer
may change or update the forecasts delivered hereunder at any time upon notice
to Supplier.
(c) Buyer acknowledges that Supplier may rely on Buyer's
thirteen (13) week forecasts for purposes of materials and production planning.
Without limitation, Buyer shall not hold Supplier accountable for any inability
to deliver Devices or Services which are required either in excess of Supplier's
predicted quantities or without suitable lead time to allow for the acquisition
of necessary materials, production capacity or other resources.
3.3 PURCHASE ORDERS AND RELEASES. Buyer will submit Purchase Orders to
Supplier to cover Buyer's expected purchases of Devices and Services. Buyer will
then submit Purchase Order Releases on a regular basis, as agreed upon by the
Parties, to any Blanket Purchase Orders. Each Purchase Order for Devices and
Services will specify, as appropriate, the applicable Purchase Order, Device
part number and revision level, quantity required by Buyer, Price, requested
delivery date, ship-to address, and other applicable information as determined
by Buyer. Notwithstanding the receipt of a Blanket Purchase Order, Supplier will
not commence manufacturing of the Devices or providing the Services under a
Blanket Purchase Order until Buyer has issued a Purchase Order Release. As a
minimum, Purchase Orders must cover the committed portion of the forecast.
3.4 ACCEPTANCE AND ACKNOWLEDGEMENT. All of Buyer's Purchase Orders for
Devices and Services, insofar as not exceeding the Purchase Commitment shall be
accepted and fulfilled by Supplier in accordance with the delivery dates
specified therein, provided that the dates requested are consistent with the
required Cycle Time for such Device or Service set forth in Exhibit A. For
Services and Devices in excess of the Purchase Commitment, Supplier shall use
commercially reasonable efforts to accept and fulfill such Purchase Orders.
Within three (3) business days after receipt of each Purchase Order, Supplier
will acknowledge such Purchase Order in writing by fax, e-mail notice, or
electronic data interchange ("EDI") to Buyer's purchasing agent identified on
the face of the Purchase Order. Such acknowledgement will include Supplier's
committed delivery date for the order; provided that, in establishing such
delivery date, Supplier shall use commercially reasonable efforts to comply with
the delivery dates specified in Buyer's Purchase Order and to meet or reduce the
Device and Service Cycle
-10-
Times set forth in Exhibit A. The Device and Service Cycle Times set forth in
Exhibit A shall be updated quarterly, upon mutual agreement of the Parties. If
at any time during the production of such Devices or providing of such Services
Supplier believes or becomes aware that the delivery may be delayed by more than
one (1) business day, Supplier shall promptly provide Buyer with written notice
of such delivery date change or any applicable quantity change. Such report
shall be referred to as an "EXCEPTION REPORT" and any Devices or Services not
specifically identified in an Exception Report shall be delivered by Supplier no
later than the committed delivery date.
3.5 DEVICE LOTS; EXPEDITED SERVICES. Unless otherwise agreed to in
writing by the Parties, Production Device Lots shall be ordered by Buyer and
delivered by Supplier in Lots of one thousand five hundred (1500) Devices to
five thousand (5000) Devices, and Engineering Device Lots shall be ordered by
Buyer and delivered by Supplier in Lots of a maximum of one thousand (1000)
Devices.
(a) EXPEDITED LOTS. At Buyer's request, Supplier will use
commercially reasonable efforts to provide priority processing of Production
Device Lots and Engineering Device Lots at no additional cost to Buyer.
Notwithstanding the foregoing, if the quantity of expedited lots requested by
Buyer exceeds six (6) Lots in process at any given time during the first year of
the Agreement, four (4) Lots during the second year of the Agreement and two (2)
Lots during the third year of the Agreement, the fee for such additional Lots
shall be five-hundred dollars ($500) per Lot. Buyer acknowledges that excessive
Lot expediting activity could increase Cycle Time for other products.
(b) ENGINEERING LOTS. Engineering Lot pricing shall include a
set-up charge per lot of three-hundred and fifty dollars ($350) and a standard
cost charged monthly as identified in Exhibit B.
3.6 CANCELLATION AND MODIFICATIONS TO ORDERS. Except as otherwise
provided in this Mexicali Agreement, Buyer may cancel, modify or reschedule a
Purchase Order (in whole or in part) as set forth in this Section 3.6; provided
that Buyer meets its Purchase Commitments.
(a) CANCELLATION BEFORE PROCESS START. For each Purchase Order
before processing the Devices or performance of the Services is started, Buyer
may cancel or modify a Purchase Order (in whole or in part) without penalty by
delivering to Supplier a written notice of cancellation or modification. Such
cancellation shall be without charge or penalty, except that Buyer shall be
obligated to purchase and pay for any materials acquired in respect of
Supplier's anticipated production or Services for Buyer as identified in Section
5.l(d).
(b) CANCELLATIONS AFTER PROCESS START. If Buyer cancels a
Purchase Order after the date the processing of such Devices and/or Services has
been started, then Supplier shall discontinue all work on the Devices and/or
Services, return the Devices to Buyer, and as Buyer's sole liability, and
Supplier's sole remedy, for such cancellation, Buyer will pay the full price for
all such Devices and/or Services as specified in Exhibit B pursuant to
Supplier's invoice.
(c) RIGHT TO CANCEL. Supplier will indicate a delivery date for
Devices and/or Services ordered by Buyer in Supplier's acknowledgement of
receipt of Buyer's Purchase Orders. After such notice has been given, any
Devices and/or Services delivered to Buyer will be deemed timely delivered if
delivery is made within fifteen (15) days of such acknowledged delivery date.
During this fifteen (15) day period, Supplier and Buyer agree to have management
of each company discuss the reasons for the delay and the possible provision of
expedited services. If delivery is not made within fifteen (15) days from the
acknowledged delivery date, then Buyer may cancel its Purchase Order for the
delayed Devices and will not be liable for payment of the delayed Devices or
Services. Buyer will be
-11-
relieved from his Purchase Commitment in the amount equal to all orders canceled
by Buyer due to this Section 3.6(c).
(d) LOT HOLDS AFTER PROCESS START. Buyer may place up to one
hundred (100) Lots on hold at any one time by delivering to Supplier a written
hold notice. After being held for a period of thirty (30) days, the Lots will be
considered inactive and Buyer shall pay for all such Devices and/or Services in
such Lots, as specified in Exhibit B. After Lots have been held for a period of
ninety (90) days, Supplier has the right to dispose of the Lots.
3.7 MATERIALS. Supplier shall be responsible for procuring all
materials required to manufacture the quantity of Devices and Services, as
forecasted and ordered by Buyer. When purchasing such materials, Supplier shall,
at a minimum, procure quantities of materials in such volume to cover shrinkage
and scrap associated with the assembly, test processes and final packing.
Notwithstanding the foregoing, Buyer shall be responsible pursuant to Section
5.l(b) for actual costs of material incurred by Supplier in procuring up to
thirteen (13) weeks of Unique Material (including, without limitation,
leadframes, substrates, trays).
3.8 SURGE CAPACITY. At any time after Buyer's submission of a Purchase
Order, Buyer may request an increase in the number of Devices to be purchased or
Services to be provided (an "INCREASE NOTICE"). If Buyer submits an Increase
Notice for additional Devices or Services, in order to meet a Purchase
Commitment, such additional orders on the Increase Notice will be accepted by
Supplier. If Buyer submits an Increase Notice for additional Devices or Services
that are not necessary to meet the Purchase Commitment, Supplier shall use
reasonable commercial efforts to provide surge capacity and accept the Increase
Notice so long as Buyer's aggregate daily production volume does not exceed 110%
of the aggregate daily average production volume described in Buyer's
then-current 13-week forecast. If Supplier cannot meet the delivery dates
specified by Buyer in an accepted Increase Notice, Supplier shall promptly
notify Buyer in writing and Buyer may, at its discretion, reduce or cancel such
Increase Notice. Supplier shall use reasonable commercial efforts to deliver all
such Devices and provide all such Services within the delivery dates specified.
Notwithstanding the foregoing, Supplier shall not be obligated to provide surge
capacity for any package style exceeding the total available capacity of the
Supplier Manufacturing Facility as identified in this Section 3.8.
Notwithstanding the above, surge capacity within package types will be limited
to material availability (including without limitation, die availability) and
Supplier will not be liable for its failure to provide surge capacity if
material is not available due to reliance on Buyer's forecast.
3.9 RISK PRODUCTION. At Buyer's request, as mutually agreeable to both
Parties, and subject to an applicable Purchase Order or Purchase Order Release,
Supplier shall consider Buyer's request to provide Risk Production to Buyer.
With all Purchase Orders for Risk Production, Buyer shall provide a written
statement setting forth the risk factors or any special circumstances related to
the Risk Production and specifying the Lot size and quantity of Risk Production
which Buyer requests be provided. Supplier's acknowledgement, including
modifications to such written statement included as part of Buyer's Purchase
Order for Risk Production, shall be deemed Supplier's acknowledgement of such
risks or circumstances. If the Parties cannot agree on the risk factors or any
special circumstances related to the Risk Production, Buyer may cancel the
applicable Purchase Order. Supplier shall use reasonable commercial efforts to
provide processing of Risk Production consistent with its ongoing operations and
other business. Risk Production is offered as a Service hereunder. WITHOUT
LIMITATION, SUPPLIER EXTENDS NO WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, WITH
RESPECT TO RISK PRODUCTION BEYOND SUPPLIER'S UNDERTAKING TO USE REASONABLE
COMMERCIAL EFFORTS IN THE COURSE OF THE MANUFACTURING OF RISK PRODUCTION.
Without limitation, compliance with the Quality Specifications and Section 7.1
and Section 7.2 shall not apply to Risk Production.
-12-
3.10 REWORK. Upon Buyer's request and as accepted in Supplier's
acknowledgement, Supplier shall provide Device rework Services for Buyer. Buyer
shall pay Supplier, in accordance with the pricing set forth in Exhibit B, for
rework Services performed by Supplier for any reason other than as required by
Section 7. No warranty is provided by Supplier for such reworked devices. If
pricing is not stated in Exhibit B, then the Parties shall mutually agree on
costs and pricing for such rework processing.
3.11 NRE SERVICES. At Buyer's request, Supplier shall provide
non-recurring engineering services for new packages, Devices or Services. The
Parties shall negotiate in good faith the terms and conditions and any
applicable costs associated with such engineering services.
4. DELIVERY AND ACCEPTANCE OF DEVICES.
4.1 DELIVERY PROCEDURE. All Devices shipped by Supplier to Buyer under
this Mexicali Agreement will be accompanied by appropriate documentation
regarding shipping location, Lot identification numbers, Buyer product number,
quantity shipped, customer name, shipping date, and purchase order number and
such other information reasonably requested by Supplier. At Buyer's option,
shipped Devices may also include relevant testing data in either hard or soft
copy, and may be accompanied by an exception report, to the extent that one
exists.
(a) TITLE AND RISK OF LOSS. Buyer shall retain title and risk of
loss for any and all die and other material provided by Buyer to Supplier for
Manufacturing Services.
(b) SHIP ALERT. Supplier will use commercially reasonable
efforts to provide Buyer with a ship alert within one (1) business day after a
shipment is made. Such ship-alert will include the freight carrier, bill number,
and number of boxes shipped, as well as the information provided on the packing
list.
4.2 DEVICES. Supplier shall process all deliveries of Devices in
inventory, and Devices provided by Buyer for Manufacturing Services, in
accordance with the shipping instructions included in the Delivery Note or
otherwise communicated to Supplier in writing. Supplier processing shall include
those processes set forth in Exhibit I. Supplier shall use reasonable commercial
efforts to complete all such processing within one (1) business day from the
receipt of the Delivery Note.
4.3 DEVICE LOGISTICS. Supplier will provide handling and receiving
services and finished goods storage for Buyer as further described in Exhibit I.
Supplier shall use reasonable commercial efforts to complete all such processing
within one (1) business day from the receipt of the goods. Upon Buyer's request
and at no additional cost to Buyer, Supplier shall hold Devices in finished
goods storage for a period not to exceed fifteen (15) months.
4.4 SHIPPING ARRANGEMENTS. Supplier will use commercially reasonable
efforts to comply with any special shipping instructions specified on Buyer's
Purchase Order or Buyers Delivery Note. In the absence of any such instructions,
Supplier will determine the method of shipment and select the carrier. Buyer
will pay, or reimburse Supplier for all shipping and handling charges. If
Supplier is required to pay such charges to the carrier, Supplier will include
such charges, as a line item in an invoice to Buyer and Buyer will pay such
amount in accordance with Section 5.l(a).
-13-
5. PRICING AND PAYMENTS.
5.1 PRICING AND INVOICES.
(a) PAYMENTS FOR ORDERED DEVICES. Supplier will invoice Buyer
for Devices and/or Services at the applicable Device or Service price calculated
pursuant to Exhibit B in effect on the date of the invoice. Each such invoice
shall be dated on or after the delivery into assembly finished goods or finished
goods and shall be itemized as agreed to by both Parties. The Parties agree that
the standards set forth in Exhibit B may be revised from time to time upon the
mutual agreement of the Parties. Buyer will pay any amounts due on such invoices
within thirty (30) days of receipt of the invoice.
(b) INACTIVE MATERIAL. Material purchased to support Buyer
forecasts, as set forth in Section 3.8, which is not consumed within one hundred
eighty (180) days of receipt will be considered "INACTIVE MATERIAL."
(i) Supplier may invoice Buyer for Supplier's cost of all
Inactive Material and handling expenses and Buyer shall pay such invoice within
thirty (30) days of its receipt. Upon receipt of such payment, the Inactive
Material will then be segregated as Buyer furnished material and, if consumed
between day one-hundred eighty one (181) and one (1) year of receipt by the
Buyer, will be credited toward future assembly Purchase Orders at Supplier's
cost as paid by Buyer.
(ii) Subject to receipt of payment, Inactive Material not
consumed within one (1) year of receipt will, at Buyer's option, be scrapped
processed for reclaim, or returned to Buyer.
(c) FINAL TEST YIELD RECONCILIATION. Supplier and Buyer shall
perform a final test yield reconciliation to adjust test services pricing on a
monthly basis. The actual yield will be compared with the financial standard
yield. The yield variance will be calculated as the delta between the financial
standard cost yield used for setting standards and the actual yield. Adjustments
made to correct yield transactions should also be taken into consideration. A
credit or debit memo will be issued from the Supplier to Buyer.
(d) MATERIAL PRICE REDUCTIONS. The Standard Price for materials
in year two (2) will be the lower of five percent (5%) less than the Standard
Price of the materials as of the Effective Date in year one (1) or the actual
cost as determined at the end of year one (1). The Standard Price of materials
in year three (3) will be the lower of five percent (5%) less than year two (2)
Standard Price or the actual cost as determined at the end of year two (2).
(e) MATERIAL SAVINGS. Supplier shall credit to Buyer's account
all Unique Material Savings. The mechanism by which Common Material Savings will
be calculated is by the process of comparing the planned Purchase Order prices,
shown in Exhibit B, with the invoice price. Common Material Savings shared will
be based on activity volume. The percentage shared with Buyer will be equal to
the Buyer assembly starts divided by the total assembly starts. Although
material savings will be calculated as set forth above, price increases shall
not be passed on to Buyer. The Parties will use reasonable commercial efforts to
calculate the material savings on a monthly basis. However, by mutual agreement,
the Parties may elect to calculate the material savings on a quarterly basis
only.
5.2 CREDIT REQUIREMENTS. If based on a then-current credit report of a
Buyer Spin-off, Supplier has an issue with the credit of such Buyer Spin-off,
Supplier shall notify such Buyer Spin-off in writing of such issue and Buyer
Spin-off shall have a period of sixty (60) days to resolve the credit issue. If
such issue is not resolved within such sixty (60) day period, Supplier reserves
the right to limit Buyer
-14-
Spin-off's purchases to a reasonable amount, such amount to be based on a
then-current credit report of the Buyer Spin-off and mutually agreed to by
Supplier and Buyer Spin-off. The foregoing shall apply to Buyer Spin-off,
notwithstanding Buyer Spin-off entering into a separate agreement with Supplier
and assuming the rights and obligations of "Buyer" hereunder. In addition, in
the event Buyer (i.e., Conexant Systems, Inc.) does not make timely payment on
Supplier's invoices and such issue is not resolved within sixty (60) days' of
receipt of Supplier's written notice of such payment delays, Supplier reserves
the right to limit Buyer's purchases to a reasonable amount, such amount to be
based on a then-current credit report of Buyer and mutually agreed to by
Supplier and Buyer.
5.3 COSTS. Except as otherwise provided herein or agreed to in
writing by the Parties, each Party will be solely responsible for the costs and
expenses it incurs in performing its obligations under this Mexicali Agreement.
5.4 TAXES. Buyer will be responsible for payment of any and all taxes
or related governmental charges, including without limitation all sales, use,
excise, and other taxes and duties ("TAXES") imposed on or arising from Buyer's
purchase of Devices or Services under this Mexicali Agreement, excluding any
Mexican IVA (value added) tax, duties, and taxes on the net income or net worth
of Supplier. Based on the Parties' understanding that all Devices will be
exported outside of Mexico, the Parties understand that no IVA or duties will be
payable. In the event either Party's requirements cause IVA or duties to be
assessed, such IVA and duties will be borne by the Party that causes the
imposition of IVA or duties. Supplier shall use reasonable commercial efforts to
minimize Taxes within Supplier's control. Taxes shall be specifically identified
by Supplier as a separate line item on Supplier's invoices provided pursuant to
Section 5.1. Upon Buyer's request, Supplier will provide Buyer with copies of
official receipts for the payment of any such Taxes, and any other information
and documents Buyer may reasonably request in order to verify the payment of
such amounts to the appropriate governmental entity.
6. TRACKING AND REPORTING.
6.1 TRACKING. All Devices manufactured and delivered by Supplier to
Buyer shall have backward and forward traceability, for a minimum period of two
(2) years, sufficient to enable Supplier to identify (i) the processes and
materials used in the manufacture of such Devices; (ii) the batches or Lots of
such materials; and (iii) other Devices in the same or sequential Lots. Such
information shall be provided to Buyer, upon Buyer's request.
6.2 REPORTING REQUIREMENTS. Supplier shall provide Buyer with the
reports specified in Exhibit J in accordance with frequency or schedule set
forth therein. All such reports shall be in writing and provided to Buyer in the
form (e.g., electronic form) specified in Exhibit J or otherwise mutually agreed
to in writing by the Parties.
6.3 RECORDS AND AUDITS. For the term of this Mexicali Agreement and
for five (5) years thereafter, Supplier shall maintain complete, current and
accurate records documenting all amounts charged to Buyer. To ensure compliance
with the terms of this Mexicali Agreement, Buyer or its designated
representative that is bound by a confidentiality agreement, shall have the
right to conduct an inspection and audit of all the relevant manufacturing and
accounting books and records of Supplier, and to obtain true and correct
photocopies thereof, during regular business hours at Supplier's offices. Any
and all information reviewed by Buyer, its representative or the third party
auditor under this Section 6.3 is Confidential Information as described in
Section 9 of this Mexicali Agreement. Buyer shall provide Supplier with at least
thirty (30) days' advance notice of any such audit and the audit shall be
conducted in a manner that does not unreasonably interfere with Supplier's
normal business activities. In no event
-15-
shall such audits be conducted more frequently than once every year. If any such
audit should disclose any overcharges, Supplier shall promptly reimburse Buyer
for any overpaid amounts, together with interest thereon at four percent (4%)
over the prime rate quoted from time to time in the Wall Street Journal, or the
highest rate allowable by law, whichever is less, from the date such amount was
paid until reimbursed by Supplier. If the audit reveals that Supplier has
overcharged Buyer by five percent (5%) or more of the amounts paid during such
audited period, then Supplier shall promptly reimburse Buyer for all actual
expenses incurred by Buyer in connection with the audit.
7. WARRANTY AND DISCLAIMER.
7.1 DEVICE WARRANTY. For a period of ninety (90) days from the date of
delivery (the "DEVICE WARRANTY PERIOD"), Supplier warrants that the Devices
delivered hereunder will conform to the applicable Specifications, will be
manufactured in accordance with the Quality Specifications specified in Exhibit
D, and will be free from defects in material, manufacturing and workmanship.
Supplier shall, at Buyer's option, promptly provide replacement Manufacturing
Services relating to such defective Devices or credit Buyer's account for the
amount paid by Buyer for such defective Devices. This warranty shall not apply
to Devices which, after delivery to Buyer, have been (i) repaired or altered
(except by, or under the direction of, Supplier) or (ii) damaged or subjected to
abuse or misuse. Warranty claims hereunder shall be made by Buyer by making a
written warranty claim within the Device Warranty Period. Except as otherwise
instructed by Supplier, Buyer shall return all defective Devices to Supplier for
inspection. Before returning Devices, Buyer shall request in writing and obtain
a Return Materials Authorization ("RMA") number from Supplier, and Supplier
shall be obligated to review such request and provide the RMA within two (2)
business days of receipt of such request, and Buyer agrees to display such RMA
number on the packaging of such returned Devices. Replacement Devices will be
warranted in accordance with this Section 7.1. THE FOREGOING REPRESENTS BUYER'S
SOLE REMEDY AND SUPPLIER'S SOLE LIABILITY IN THE EVENT OF A BREACH OF THE DEVICE
WARRANTY IN THIS SECTION 7.1.
7.2 SERVICES WARRANTY. For a period of ninety (90) days from
completion of performance of the applicable Service (the "SERVICES WARRANTY
PERIOD"), Supplier warrants that such Services will be provided in accordance
with the performance metrics mutually agreed by the Parties including quality,
yield, and Cycle Time and, in any event, in a professional and workmanlike
manner. If, during the Services Warranty Period, Supplier is notified in writing
of any breach of this warranty, then Supplier shall, at Buyer's option, and as
Supplier's sole liability with respect to such breach of warranty, promptly
re-perform such Services or credit Buyer for such Services. Re-performed
Services will be warranted in accordance with this Section 7.2. THE FOREGOING
REPRESENTS BUYER'S SOLE REMEDY AND SUPPLIER'S SOLE LIABILITY IN THE EVENT OF A
BREACH OF THE SERVICES WARRANTY IN THIS SECTION 7.2.
7.3 DISCLAIMERS. EXCEPT FOR THE EXPRESS WARRANTIES SET FORTH IN THIS
MEXICALI AGREEMENT, NEITHER PARTY MAKES ANY REPRESENTATIONS OR WARRANTIES,
EXPRESS OR IMPLIED OR OTHERWISE, IN CONNECTION WITH THIS MEXICALI AGREEMENT OR
ANY DEVICES OR SERVICES PROVIDED UNDER THIS MEXICALI AGREEMENT, AND EACH PARTY
SPECIFICALLY DISCLAIMS THE IMPLIED WARRANTIES AND CONDITIONS OF MERCHANTABILITY,
FITNESS FOR PARTICULAR PURPOSE AND NONINFRINGEMENT.
-16-
8. INDEMNIFICATION.
8.1 INDEMNIFICATION OBLIGATIONS.
(a) BUYER INDEMNITY. Buyer will defend at its own expense any
claim, suit, or action (collectively, "CLAIMS") asserted or brought against
Supplier by a third party to the extent that such Claim is based on a claim that
Supplier's compliance with Buyer's specifications or designs in the production
or sale of Devices or Services required the infringement of any United States or
Mexican patent or misappropriation of any trade secret (a "BUYER
INFRINGEMENT CLAIM"). Buyer will pay such damages awarded against Supplier by a
court of competent jurisdiction, or agreed to in a monetary settlement of any
such Claim by Buyer, to the extent that such damages are directly attributable
to a Buyer Infringement Claim. Buyer's indemnification obligation will not apply
to Buyer Infringement Claims that result from or are attributable to (a) any
modifications, combinations, or improvements made to the design or specification
as furnished to Supplier by Buyer (except for modifications, combinations and
improvements requested by Buyer); or (b) use of the design or specification by
Supplier for any purpose other than providing Devices or Manufacturing Services
to Buyer, if such claim under (a) or (b) would not have arisen but for such
modification, combination, improvement or use.
(b) SUPPLIER INDEMNITY. Supplier will defend at its own expense
any Claims asserted or brought against Buyer by a third party to the extent that
such Claim is based on a claim that Supplier's technology, equipment, or methods
used to manufacture the Devices or to provide the Services infringes any United
States or Mexican patent or misappropriates any trade secret (a "SUPPLIER
INFRINGEMENT CLAIM"). Supplier will pay such damages awarded against Buyer by a
court of competent jurisdiction, or agreed to in a monetary settlement of any
such Claim by Supplier, to the extent that such damages are directly
attributable to a Supplier Infringement Claim. Supplier's indemnification
obligation will not apply to Supplier Infringement Claims that result from, or
are attributable to: (a) compliance with Buyer's designs or specifications; (b)
any modifications, combinations, or improvements made to the Devices after
delivery to Buyer; or (c) use of the Devices or Services for any unintended
purpose, if such claim under (a), (b) or (c) would not have arisen but for such
compliance, modifications, combination, improvement or use. In the event the
Devices or Services are deemed to infringe and their manufacture, use or sale is
enjoined, Supplier shall, at its option, either (i) arrange for Buyer to have
the right to continue using the Devices or receiving the Services, or (ii)
provide replacements for the Devices or Services with non-infringing comparable
devices or services meeting Buyer's requirements. If neither of the foregoing in
(i) or (ii) are commercially practicable, then Supplier shall accept return of
the Devices, discontinue the Services, and refund Buyer's purchase price in
respect of the Devices and/or Services, as the case may be.
8.2 CONDITIONS. The obligations of the indemnifying Party (the
"INDEMNIFYING PARTY") under this Section 8 with respect to a Buyer Infringement
Claim or Supplier Infringement Claim (as applicable) (an "INFRINGEMENT CLAIM")
are subject to the following conditions: (a) the indemnified Party (the
"INDEMNIFIED PARTY") must promptly notify the Indemnifying Party in writing of
such Infringement Claim; (b) the Indemnifying Party must have sole control of
the defense and settlement of the Infringement Claim; and (c) the Indemnified
Party must fully cooperate with and provide reasonable assistance to the
Indemnifying Party in the defense and settlement of such Infringement Claim
(which includes furnishing to the Indemnifying Party all evidence in the
possession of the Indemnified Party that is relevant to such Infringement
Claim). Solely to the extent a proposed settlement or stipulated judgment
adversely affects the Indemnified Party, the Indemnifying Party will not accept
a settlement or stipulated judgment of any Buyer Infringement Claim or Supplier
Infringement Claim (as applicable) without the prior written consent of the
Indemnified Party, which consent will not be unreasonably withheld or delayed.
The Indemnifying Party will have no liability under this Section 8 for any
costs, losses,
-17-
liabilities, or damages resulting from the willful acts of the Indemnified Party
or any settlement or compromise incurred or made by the Indemnified Party
without the Indemnifying Party's prior written consent. The Indemnified Party
will have the right to participate, at its own expense, in the defense or
settlement of the Infringement Claim.
8.3 SOLE AND EXCLUSIVE REMEDY. THIS SECTION 8 STATES THE INDEMNIFYING
PARTY'S ENTIRE LIABILITY AND THE INDEMNIFIED PARTY'S SOLE REMEDY WITH RESPECT TO
THE INFRINGEMENT, VIOLATION, OR MISAPPROPRIATION OF ANY INTELLECTUAL PROPERTY
RIGHTS OF ANY THIRD PARTY ARISING FROM OR RELATING TO THIS MEXICALI AGREEMENT.
EACH PARTY'S OBLIGATIONS UNDER THIS SECTION 8 ARE SUBJECT TO THE LIMITATIONS OF
LIABILITY SET FORTH IN SECTION 10.
9. CONFIDENTIALITY.
9.1 CONFIDENTIALITY OBLIGATIONS. The receiving Party ("RECIPIENT")
will hold the Confidential Information of the disclosing Party ("PROVIDER") in
strict confidence and, except as set forth herein or allowed under Section 9.2,
will not disclose, provide, or otherwise make available such Confidential
Information to any person other than Recipient's employees and independent
contractors who need to have access to such Confidential Information in order
for the Recipient to exercise its rights or perform its obligations under this
Mexicali Agreement. The Recipient will inform each such employee and independent
contractor of the Recipient's confidentiality obligations under this Mexicali
Agreement, and will ensure that each such employee and independent contractor
has signed a non-disclosure agreement containing terms no less restrictive than
the terms of this Section 9. Each Party will be liable for any breach of this
Section 9.1 by any of its employees or independent contractors. The Recipient
will use the Provider's Confidential Information solely to exercise its rights
or perform its obligations under this Mexicali Agreement and for no other
purpose. The Recipient will protect the confidentiality of the Provider's
Confidential Information using at least the same efforts Recipient uses to
protect its own confidential and proprietary information of similar nature, but
in no event less than reasonable efforts. The Recipient will return the
Provider's Confidential Information to the Provider promptly upon the Provider's
request or termination of this Mexicali Agreement; provided that, if the
Recipient has continuing rights or obligations or liabilities under this
Mexicali Agreement, the Recipient may retain a copy of any Provider Confidential
Information reasonably required to exercise its rights or perform such
obligations solely for the period of time required to meet such obligations.
Supplier acknowledges and agrees that Buyer may disclose the Confidential
Information of Supplier to Buyer Subsidiaries and employees of such Buyer
Subsidiaries, in accordance with the restrictions set forth above and Buyer will
be liable for any breach of this Section 9.1 by such Buyer Subsidiaries or its
employees.
9.2 EXCEPTIONS. Disclosure of Confidential Information will be
permitted to the extent required to comply with a valid order of a court or
governmental authority with jurisdiction over the Recipient, provided that the
Provider has been given timely notice of such requirement and that the Recipient
must cooperate with the Provider to limit the scope and effect of such order.
The Recipient's obligations under Section 9.1 with respect to any Confidential
Information of the Provider will terminate if and when the Recipient can prove
by clear and convincing evidence that such Confidential Information (i) was
rightfully in possession of the Recipient, without restriction, prior to
disclosure; (ii) was rightfully received by the Recipient without restriction
from a third party not owing a duty of confidentiality to the Provider; (iii) is
generally available to the public without fault of the Recipient; or (iv) is
independently created by the Recipient.
9.3 CONFIDENTIALITY OF THIS MEXICALI AGREEMENT. Neither Party will
disclose any terms of this Mexicali Agreement to anyone other than (i) its
attorneys, accountants, and other professional
-18-
advisors under a duty of confidentiality; (ii) its subsidiaries, spin-offs, and,
in the event of a merger or acquisition, prospective successor, all of the
foregoing under a duty of confidentiality; and (iii) as required by law or
pursuant to a mutually agreeable press release.
9.4 INJUNCTIVE RELIEF. Each Party acknowledges and agrees the other
Party would suffer irreparable harm for which monetary damages would be an
inadequate remedy if there were a breach of obligations under Section 9.1. Each
Party further acknowledges and agrees that equitable relief, including
injunctive relief, would be appropriate to protect the other Party's rights and
interests if such a breach were to arise, were threatened, or were asserted.
10. LIMITATIONS OF LIABILITY.
10.1 DISCLAIMER. EXCEPT AS OTHERWISE EXPRESSLY PROVIDED IN THIS
MEXICALI AGREEMENT, IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER PARTY
FOR LOST PROFITS OR FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR
EXEMPLARY DAMAGES ARISING FROM THE SUBJECT MATTER OF THIS MEXICALI AGREEMENT,
REGARDLESS OF THE TYPE OF CLAIM AND EVEN IF THAT PARTY HAS BEEN ADVISED OF THE
POSSIBILITY OF SUCH DAMAGES.
10.2 LIABILITY LIMITATION. EXCEPT AS SPECIFICALLY AND EXPRESSLY
PROVIDED BELOW, IN NO EVENT WILL EITHER PARTY'S AGGREGATE, CUMULATIVE LIABILITY
TO THE OTHER ARISING OUT OF OR RELATING TO THIS MEXICALI AGREEMENT, INCLUDING
ANY APPLICABLE PENALTIES, EXCEED THE GREATEST OF: (a) $250,000 OR (b) THE
AGGREGATE OF ALL AMOUNTS PAID AND OWED TO SUPPLIER PURSUANT TO THIS MEXICALI
AGREEMENT DURING THE PRECEDING 12-MONTH PERIOD. BUYER'S LIABILITY FOR PURCHASE
COMMITMENTS AS DEFINED IN SECTION 2.1(a) WILL NOT BE LIMITED BY THIS SECTION
10.2. THIS LIMITATION ON LIABILITY IS CUMULATIVE WITH ALL PAYMENTS BEING
AGGREGATED TO DETERMINE SATISFACTION OF THE LIMIT. THE EXISTENCE OF ONE OR MORE
CLAIMS OR SUITS WILL NOT ENLARGE THE LIMIT.
10.3 BASIS OF BARGAIN. EACH PARTY ACKNOWLEDGES THAT THE MUTUAL
LIMITATIONS OF LIABILITY CONTAINED IN THIS SECTION 10 REFLECT THE ALLOCATION OF
RISK SET FORTH IN THIS MEXICALI AGREEMENT AND THAT EACH PARTY WOULD NOT ENTER
INTO THIS MEXICALI AGREEMENT WITHOUT THESE LIMITATIONS ON LIABILITY.
11. TERM AND TERMINATION.
11.1 TERM. This Mexicali Agreement will take effect on the Effective
Date and will remain in effect for a period of three (3) years from the
Effective Date (the "INITIAL TERM"), unless earlier terminated in accordance
with this Section 11. Following the Initial Term, this Mexicali Agreement may be
renewed for additional one-year renewal terms (each a "RENEWAL TERM"), upon
mutual agreement of the Parties.
11.2 TERMINATION. This Mexicali Agreement, or any Purchase Order issued
hereunder, may be terminated as follows:
(a) immediately upon written agreement of the Parties;
-19-
(b) immediately upon the expiration of the ninety (90) day cure
period, if a Party materially breaches any section of this Supply Agreement and
such breach is not cured within ninety (90) days after written notice of such
breach is furnished by the non-breaching Party;
(c) by either Party, at its discretion immediately upon
providing written notice to the other Party, if within any period of twelve (12)
months there are five (5) or more material breaches or failures by the other
Party that would constitute grounds for termination pursuant to this Section
11.2 (without giving effect to cure periods), regardless of whether such
breaches or failures were cured within the applicable cure periods and provided
that: (i) such repeated material breaches collectively have a material impact on
the non-breaching Party's business, and (ii) the Parties have failed to
satisfactorily resolve the material breach issue in accordance with the
escalation procedure set forth in Section 12.3;
(d) subject to Section 2.2(e), immediately in the event of any
closure of the Supplier Manufacturing Facility;
(e) by Buyer upon six (6) months written notice in the event of
a sale, transfer, assignment or other change-of-control of the Supplier
Manufacturing Facility to a third party that is reasonably determined to be a
Competitor of Buyer or its affiliates;
(f) by Buyer upon eighteen (18) months written notice in the
event of a sale, transfer, assignment or other change-of-control of the Supplier
Manufacturing Facility to any third party; and
(g) immediately upon written notice by either Party, at its
discretion, if (i) the other Party becomes insolvent, admits in writing its
inability to pay its debts as they become due, or files or has filed against it
any proceeding in bankruptcy or for reorganization under any federal bankruptcy
law or similar state law, or has any receiver appointed for all or a substantial
part of such Party's assets or business, or makes any assignment for the benefit
of its creditors, or enters into any other proceeding for debt relief, and such
proceeding is not dismissed within sixty (60) days of filing; (ii) the other
Party dissolves, liquidates, or institutes any proceedings for the liquidation
or winding up of its business or for the termination of its corporate charter;
or (iii) the other Party ceases to conduct its business in the ordinary course.
11.3 EFFECT OF TERMINATION. The rights and obligations under Sections 1
(Definitions), 5 (Pricing and Payments), 7 (Warranty and Disclaimer), 8
(Indemnification), 9 (Confidentiality), 10 (Limitations of Liability), 11.3
(Effect of Termination), and 12 (General) will survive termination or expiration
of this Mexicali Agreement for any reason. Buyer's obligations under Section
2.1(a) (Purchase Commitments) with respect to any final partial quarter of the
term shall also survive, and be equitably determined pursuant to Section 2 by
prorating the annual and/or quarterly Purchase Commitments, as the case may be.
11.4 TERMINATION OF BUYER SPIN-OFF AGREEMENTS. In addition to the
termination rights set forth in Section 11.2, Supplier shall have the right to
terminate without cause a Buyer Spin-off Agreement entered into pursuant to
Section 2.1(e) upon six (6) months prior written notice to such Buyer Spin-off
in the event such Buyer Spin-off is merged with or acquired by an entity that is
reasonably deemed to be a Competitor of Supplier; provided that Supplier will
continue to manufacture, supply, and provide to Buyer Spin-off, in accordance
with the Device and Service purchase procedures of such Buyer Spin-off
Agreement, any Devices or Services ordered by such Buyer Spin-off for delivery
prior to the expiration of such six (6) month period. This Section 11.4 shall be
incorporated in the Buyer Spin-off Agreements and
-20-
shall apply to Buyer Spin-offs, notwithstanding such Buyer Spin-offs assuming
the rights and obligations of "Buyer" under this Agreement.
12. GENERAL.
12.1 NO AGENCY. Under this Mexicali Agreement (i) each Party will be
deemed to be an independent contractor and not an agent, joint venturer, or
representative of the other Party; (ii) neither Party may create any obligations
or responsibilities on behalf of or in the name of the other Party; and (iii)
neither Party will hold itself out to be a partner, employee, franchisee,
representative, servant, or agent of the other Party.
12.2 GOVERNING LAW; VENUE AND JURISDICTION. This Mexicali Agreement
will be governed by, subject to, and construed in accordance with the internal
laws of the State of California, as such laws apply to contracts between
California residents performed entirely within California. Venue for any dispute
however arising under this Mexicali Agreement shall be in Orange County,
California and both Parties hereby consent to the jurisdiction of the State and
Federal Courts in Orange County, California. The Parties agree that the United
Nations Convention on Contracts for the International Sale of Goods will not
apply to this Mexicali Agreement.
12.3 DISPUTE RESOLUTION AND ESCALATION.
(a) In the event that any dispute, claim or controversy
(collectively, a "DISPUTE") arises out of or relates to any provision of this
Mexicali Agreement or the breach, performance or validity of invalidity thereof,
an appropriate authorized manager of Buyer and an appropriate authorized manager
of Supplier shall attempt a good faith resolution of such Dispute within thirty
(30) days after either Party notifies the other Party of such Dispute. If such
Dispute is not resolved within thirty (30) days of such notification, such
Dispute will be referred for resolution to Supplier's President and Buyer's
Chief Executive Office. Should they be unable to resolve such Dispute within
thirty (30) days following such referral to them, or within such other time as
they may agree, Supplier and Buyer shall submit such Dispute to binding
arbitration, initiated and conducted in accordance with the then-existing
American Arbitration Association Commercial Arbitration Rules, before a single
arbitrator selected jointly by Supplier and Buyer. If Supplier and Buyer cannot
agree upon the identity of an arbitrator within ten (10) days after the
arbitration process is initiated, then the arbitration shall be conducted before
three (3) arbitrators, one (1) selected by Buyer and, one (1) selected by
Supplier, and the third selected by the first two. The arbitration shall be
conducted in the County of Orange, California and shall be governed by the
United States Arbitration Act, 9 USC Sections 116, and judgment upon the award
may be entered by any court having jurisdiction thereof. The arbitrator(s) shall
have case management authority and shall resolve the Dispute in a final award
within one hundred eighty (180) days from the commencement of the arbitration
action, subject to any extension of time thereof allowed by the arbitrators upon
good cause shown. There shall be no appeal from the arbitral award, except for
fraud committed by an arbitrator in carrying out his or her duties under the
aforesaid rules; otherwise the Parties irrevocably waive their rights to
judicial review of any Dispute arising out of or related to this Mexicali
Agreement. Notwithstanding the foregoing, either Party may pursue immediate
equitable relief in the event of a breach of Section 9 or an alleged violation
or misappropriation of the intellectual property rights of either Party.
(b) During any period in which the Parties are resolving a
Dispute pursuant to this Section 12.3, the Parties shall continue to provide the
Devices and Services pursuant to the terms of this Mexicali Agreement; provided,
however, that if the Parties jointly determine that any such Devices or Services
shall be suspended during the period in which the Parties are resolving a
Dispute, then the deadlines and time periods in which such Devices or Services
are to be provided pursuant to this Mexicali
-21-
Agreement (as described herein) shall be extended for the same amount of time as
the Devices or Services were suspended.
12.4 THIRD-PARTY BENEFICIARIES. Except for Buyer Spin-offs, there are
no third party beneficiaries of this Mexicali Agreement. Except for the rights
of Buyer Spin-offs to purchase Devices and Services from Supplier at the pricing
established under this Mexicali Agreement, no section of this Mexicali
Agreement, express or implied, is intended or will be construed to confer upon
or give to any customer or other person other than the Parties any rights,
remedies, or other benefits under or by reason of this Mexicali Agreement.
12.5 COMPLIANCE WITH LAW. The Parties will at all times comply with all
applicable foreign, U.S., state, and local laws, rules and regulations relating
to the execution, delivery and performance of this Mexicali Agreement. Each
Party agrees that it will not export or reexport, resell, ship, provide, or
divert or cause to be exported or reexported, resold, shipped, provided, or
diverted directly or indirectly any software, documentation, or technical data,
nor any Device or Service to any country or to any person or entity for which
the government (or any agency thereof) of the United States, or any foreign
sovereign government with competent jurisdiction requires an export license or
other governmental approval without first obtaining such license or approval.
12.6 FORCE MAJEURE. Neither Party shall be liable for failure or delay
in performance of its obligations under this Mexicali Agreement to the extent
such failure or delay is caused by an act of God, act of a public enemy, war or
national emergency, rebellion, insurrection, riot, epidemic, quarantine
restriction, fire, flood, explosion, storm, earthquake, or other catastrophe. If
a Party's performance under this Mexicali Agreement is affected by a force
majeure event, such Party shall give prompt written notice of such event to the
other Party and shall at all times use its reasonable commercial efforts to
mitigate the impact of the force majeure event on its performance under this
Mexicali Agreement. In the event of a force majeure event as described in this
Section that affects either or both Parties' ability to perform under this
Supply Agreement, the Parties agree to cooperate in good faith in order to
resume the transactions contemplated by this Supply Agreement as soon as
commercially possible to the extent commercially reasonable.
12.7 AMENDMENT; LATER AGREEMENT. This Mexicali Agreement may not be
amended, modified, or supplemented by the Parties in any manner, except by an
instrument in writing signed by Buyer and Supplier and specifically reciting
that it amends this Mexicali Agreement. No purchase order or acknowledgement
will amend this Mexicali Agreement. All matters designated herein as subject to
agreement of the Parties must be agreed upon in a writing signed by authorized
representatives of both Parties for such agreement to be effective.
12.8 NOTICES. Any notice, consent, approval, or other communication
intended to have legal effect to be given under this Mexicali Agreement (other
than a purchase order or invoice) must be in writing and will be delivered (as
elected by the Party giving such notice): (i) personally; (ii) by postage
prepaid registered or certified airmail, return receipt requested; (iii) by
express courier service providing proof of delivery; or (iv) by facsimile with a
confirmation copy deposited prepaid with an express courier service. Unless
otherwise provided herein, all notices will be deemed to have been duly given
on: (y) the date of receipt (or if delivery is refused, the date of such
refusal) if delivered personally, by mail, or by express courier; or (z) one (1)
business day after receipt by telecopy if the telecopy was accompanied by the
mailing of the notice via courier service. Each Party may change its address for
purposes hereof on not less than three (3) days' prior notice to the other
Party. Notice hereunder will be sent to the following addresses:
-22-
If to Buyer, to: If to Supplier, to:
Conexant Systems, Inc. Alpha Industries, Inc.
0000 Xxxxxxxx Xxxx 00 Xxxxxxxx Xxxxx
Xxxxxxx Xxxxx, XX 00000-0000 Xxxxxxxxx, XX 00000-0000
Attn: Chief Executive Officer Attn: President
With a copy:
If to Buyer, to: If to Supplier, to:
Conexant Systems, Inc. Alpha Industries, Inc.
0000 Xxxxxxxx Xxxx 00 Xxxxxxxx Xxxxx
Xxxxxxx Xxxxx, XX 00000-0000 Xxxxxxxxx, XX 00000-0000
Attn: General Counsel Attn: General Counsel
12.9 ASSIGNMENT. Except as otherwise expressly provided in this
Mexicali Agreement, neither Party shall assign or transfer this Mexicali
Agreement or all or any part of its rights or obligations hereunder, by
operation of law or otherwise, without the prior written consent of the other
Party which shall not be unreasonably refused or delayed. Notwithstanding the
foregoing and provided such entity is not a Competitor of the other Party,
either Party may assign this Mexicali Agreement in whole or in part (i) to any
Subsidiary; (ii) to a successor of such Party in the event of a merger or
acquisition of such Party; or (iii) to a successor of any portion of the
business of such Party resulting from a divestiture of such business, and
constituting the Supplier Manufacturing Facility in the case of Supplier, or
constituting all of Buyer's business(es) purchasing the Devices and Services in
the case of Buyer, and the other Party's consent to any of the foregoing
assignments will not be required. Any subsequent assignment by an assignee, by
operation of law or otherwise, requires the prior written consent of the
non-assigning Party. Any unauthorized assignment or transfer shall be null and
void. This Mexicali Agreement shall be binding upon and inure solely to the
benefit of each Party and its successors and permitted assigns.
12.10 WAIVER. If a Party fails to insist on performance of any of the
terms and conditions, or fails to exercise any of its rights or privileges of
this Mexicali Agreement, such failure will not constitute a waiver of such
terms, conditions, rights, or privileges.
12.11 SEVERABILITY. If the application of any section or sections of
this Mexicali Agreement to any particular facts or circumstances is held to be
invalid or unenforceable by any court of competent jurisdiction, then: (i) the
validity and enforceability of such section or sections as applied to any
other particular facts or circumstances and the validity of other sections of
this Mexicali Agreement will not in any way be affected or impaired thereby; and
(ii) such section or sections will be reformed without further action by the
Parties and only to the extent necessary to make such section or sections
valid and enforceable when applied to such particular facts and circumstances.
12.12 COUNTERPARTS AND FACSIMILE. This Mexicali Agreement may be
executed in any number of counterparts, each of which when so executed and
delivered will be deemed an original, and such counterparts together will
constitute one and the same instrument. The Parties intend that each Party will
receive a duplicate original of the counterpart copy or copies executed by it.
For purposes hereof, a facsimile copy of this Mexicali Agreement, including the
signature pages hereto, will be deemed to be an original.
12.13 RULES OF CONSTRUCTION. As used in this Mexicali Agreement, all
terms used in the singular will be deemed to include the plural, and vice versa,
as the context may require. The words "hereof," "herein," and "hereunder" refer
to this Mexicali Agreement as a whole, including the attached
-23-
exhibits, as the same may from time to time be amended or supplemented, and not
to any subdivision in this Mexicali Agreement. When used in this Mexicali
Agreement, unless otherwise expressly stated, "including" means "including,
without limitation" and "discretion" means sole discretion. Unless otherwise
expressly stated, when a Party's approval or consent is required under this
Mexicali Agreement, such Party may grant or withhold its approval or consent in
its discretion. References to "Section" or "Exhibit" will be to the applicable
section or exhibit of this Mexicali Agreement. Descriptive headings are inserted
for convenience only and will not be utilized in interpreting the Mexicali
Agreement. This Mexicali Agreement has been negotiated by the Parties and
reviewed by their respective counsel and will be fairly interpreted in
accordance with its terms and without any strict construction in favor of or
against either Party.
12.14 ENTIRE AGREEMENT. As to the subject matter hereof: (i) this
Mexicali Agreement, including its exhibits, sets forth the entire agreement
between Buyer and Supplier; (ii) no promise, inducement, understanding, or
agreement not expressly contained herein has been made; and (iii) this Mexicali
Agreement merges and supersedes any and all previous agreements, understandings,
and negotiations between the Parties.
[THIS SPACE INTENTIONALLY LEFT BLANK]
-24-
IN WITNESS WHEREOF, the Parties have executed this Mexicali Agreement as
of the Effective Date by the undersigned duly authorized representatives of each
Party.
CONEXANT SYSTEMS, INC. ALPHA INDUSTRIES, INC.
By: /s/ Xxxxxx X. X'Xxxxxx By: /s/ Xxxx X. Xxxxxxx
------------------------------- -------------------------------
Name: Xxxxxx X. X'Xxxxxx Name: Xxxx X. Xxxxxxx
---------------------------- ----------------------------
Title: Senior Vice President, Title: Vice President and
---------------------------- ----------------------------
General Counsel & Secretary Chief Financial Officer
25.
EXHIBIT A - CYCLE TIMES
AVERAGE DEVICES PROCESS CYCLE TIME FOR BROADBAND PRODUCTS:
--------------------------------------------------------------------------------
Device Assembly Cycle time [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
Device Test [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
Post Test (Includes Bake *) [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
* Bake parts at 125(degree)C +/- 5(degree)C for time specified per QS03-0805
These Cycle Times are for planning purposes only and not an obligation for
delivery, but the company will work to meet these Cycle Times. The assembly
cycle time will start from Die attach to operation 485 and for test will be from
test issue room (output) to the receiving operation (885) in finish good.
Note:
Lots that require engineering analysis will not be considered for cycle time
calculation
AVERAGE DEVICES PROCESS CYCLE TIME FOR MINDSPEED PRODUCTS:
---------------------------------
Queue Time 1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
---------------------------------
Assembly Cycle time [CONFIDENTIAL TREATMENT REQUESTED]/*/
---------------------------------
Queue Time 2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
---------------------------------
Test Cycle time [CONFIDENTIAL TREATMENT REQUESTED]/*/
---------------------------------
Packing time [CONFIDENTIAL TREATMENT REQUESTED]/*/
---------------------------------
Queue Time 3 [CONFIDENTIAL TREATMENT REQUESTED]/*/
---------------------------------
TOTAL [CONFIDENTIAL TREATMENT REQUESTED]/*/
Note:
Lots that require engineering analysis will not be considered for cycle time
calculation
--------------------------------------------------------------------------------
Lead Time: From Lot created in PROMIS to the day placed in to MSPD FG
inventory.
Queue Time 1: From 1st day in Mexicali to the day of Assy Start in Dieattach.
Assy C/T: From day of Assy start Dieattach to out day of QA 485 last stage
@ Assy
Queue Time 2: Time between last stage of Assy and first time of Mextest Area.
Test C/T: From 1st day @ test area to last stage of Post Test
Op.(Bake/scanner)
Packing Time: From Last stage of Post Test Op. to the day of acceptance in to
CNXT SAP
Queue Time 3: From the day of acceptance in CNXT SAP to Shipment to MSPD.
--------------------------------------------------------------------------------
AVERAGE TAPE AND REEL CYCLE TIME
------------------------------------------
Average Tape/Reel Cycle Time [CONFIDENTIAL TREATMENT REQUESTED]/*/
------------------------------------------
26.
EXHIBIT B - PRICING
The Parties may change these costs by mutual written agreement in the event of
any errors in calculating or if there is a greater than 15% change in test
times.
YIELD ASSEMBLY COST
-------------------------------------------------------------------
PARTNAME PARTID YIELDED ASSEMBLY COST
-------------------------------------------------------------------
06815-25-A-002-A 06815-25-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06815-36-A-003-A 06815-36-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06827-14-A-024-A 06827-14-A-024-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06829-11-A-001-A 06829-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06830-16-A-010-A 06830-16-A-010-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06830-16-A-012-A 06830-16-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06831-12-A-002-A 06831-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06832-11-A-001-A 06832-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06832-12-A-002-A 06832-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06834-11-A-001-A 06834-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06834-12-A-002-A 06834-12-A-002-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06835-14-A-002-A 06835-14-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06835-25-A-001-A 06835-25-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
06836-11-A-011-A 06836-11-A-011-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
07202-11-A-001-A 07202-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11235-14-A-003-A 11235-14-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11246-12-A-001-A 11246-12-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11247-11-A-011-A 11247-11-A-011-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11247-12-A-012-A 11247-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11252-11-A-011-A 11252-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11252-15-A-015-A 11252-15-A-015-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11473-12-A-001-A 11473-12-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11558-11-A-001-A 11558-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11562-11-A-001-A 11562-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11577-11-A-001-A 11577-11-A-001-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11596-21-A-002-A 11596-21-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11609-11-A-001-A 11609-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11614-71-A-013-A 11614-71-A-013-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11614-72-A-014-A 11614-72-A-014-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11614-81-A-015-A 11614-81-A-015-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11614-82-A-016-A 11614-82-A-016-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11623-20-A-005-A 11623-20-A-005-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11627-31-A-031-A 11627-31-A-031-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11634-11-A-001-A 11634-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
11661-11-A-001-A 11661-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
20415-11-A-001-A 20415-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
20431-21-A-001-A 20431-21-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
20437-11-A-001-A 20437-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
20438-11-A-011-A 20438-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
27.
20441-11-A-001-A 20441-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
20463-11-A-001-A 20463-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
20468-21-A-001-A 20468-21-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
24105-13-A-001-B 24105-13-A-001-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
24106-15-A-002-C 24106-15-A-002-C.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
24110-11-A-001-A 24110-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
24408-16-A-002-A 24408-16-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
24942-13-A-001-B 24942-13-A-001-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25473-12-A-001-A 25473-12-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25473-13-A-001-A 25473-13-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25827-14-A-004-B 25827-14-A-004-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25829-18-A-007-B 25829-18-A-007-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25835-14-A-004-A 25835-14-A-004-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25852-11-A-001-C 25852-11-A-001-C.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25860-14-A-002-A 25860-14-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25861-14-A-002-A 25861-14-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25864-19-A-005-A 25864-19-A-005-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25865-17-A-004-A 25865-17-A-004-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25865-17-A-004-B 25865-17-A-004-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25868-16-A-004-B 25868-16-A-004-B.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25869-15-A-003-C 25869-15-A-003-C.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
25869-16-A-004-B 25869-16-A-004-B.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
30988-11-A-001-A 30988-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
30991-13-A-002-A 30991-13-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
30999-11-A-001-A 30999-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
31004-11-A-001-A 31004-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
31005-11-A-001-A 31005-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
31008-11-A-001-A 31008-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
31010-11-A-001-A 31010-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
31015-11-A-001-A 31015-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
88168-12-A-002-A 88168-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
C7504-12-A-012-A C7504-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
C7505-12-A-012-A C7505-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
C8103-13-A-002-A C8103-13-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
D9450-13-A-002-A D9450-13-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
D9450-14-A-006-A D9450-14-A-006-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
D9450-15-A-001-A D9450-15-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L1902-11-A-011-A L1902-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L2701-12-A-002-A L2701-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L2701-15-A-005-A L2701-15-A-005-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L2702-12-A-002-A L2702-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L2702-15-A-005-A L2702-15-A-005-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L2800-38-A-001-A L2800-38-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L2800-40-A-001-A L2800-40-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L3903-54-A-162-A L3903-54-A-162-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
L5502-11-A-001-A L5502-11-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P2106-21-A-001-A P2106-21-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
-28-
P2106-22-A-002-A P2106-22-A-002-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P2107-11-A-001-A P2107-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P4601-11-A-001-A P4601-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P5200-12-A-012-A P5200-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P5200-12-A-022-A P5200-12-A-022-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P8773-91-A-001-A P8773-91-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P9373-11-A-001-A P9373-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P9373-12-A-002-A P9373-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
P9573-11-A-001-A P9573-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R1060-16-A-001-A R1060-16-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6522-33-A-001-A R6522-33-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6641-15-A-012B R6641-15-A-012B.05 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6642-25-A-009-A R6642-25-A-009-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6645-18-A-001-A R6645-18-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6653-12-A-001-B R6653-12-A-001-B.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6653-13-A-002-A R6653-13-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6653-15-A-004-A R6653-15-A-004-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6653-16-A-005-A R6653-16-A-005-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6653-20-A-009-A R6653-20-A-009-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6657-14-A-004-A R6657-14-A-004-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6657-16-A-007-A R6657-16-A-007-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6664-12-A-002-A R6664-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6675-58-A-030-A R6675-58-A-030-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6682-28-A-004-A R6682-28-A-004-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6686-11-A-001-A R6686-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6713-20-A-003-A R6713-20-A-003-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6713-22-A-004-A R6713-22-A-004-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6713-24-A-134-A R6713-24-A-134-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6713-26-A-135-A R6713-26-A-135-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6713-27-A-136-A R6713-27-A-136-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6713-29-A-138-A R6713-29-A-138-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6715-14-A-004-A R6715-14-A-004-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6719-11-A-019-A R6719-11-A-019-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6719-12-A-014-A R6719-12-A-014-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6719-12-A-020-A R6719-12-A-020-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6732-13-A-002-AA R6732-13-A-002-AA.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6732-13-A-003-A R6732-13-A-003-A.04 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6753-14-A-014A R6753-14-A-014-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6753-15-A-006-A R6753-15-A-006-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6753-50-A-050-A R6753-50-A-050-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6753-72-A-072-A R6753-72-A-072-A.04 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6753-85-A-085-A R6753-85-A-085-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6753-86-A-086-A R6753-86-A-086-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6758-13-A-003-A R6758-13-A-003-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6758-14-A-001-A R6758-14-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6758-15-A-002-A R6758-15-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6758-16-A-004-A R6758-16-A-004-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
29.
R6764-21-A-121-A R6764-21-A-121-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-24-A-024-A R6764-24-A-024-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-26-A-126-A R6764-26-A-126-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-28-A-127-A R6764-28-A-127-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-29-A-029-A R6764-29-A-029-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-38-A-038-A R6764-38-A-038-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-61-A-261-B R6764-61-A-261-B-01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-62-A-362-B R6764-62-A-362-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-63-A-263-A R6764-63-A-263-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-65-A-165-B R6764-65-A-165-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-67-A-167-A R6764-67-A-167-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-68-A-168-A R6764-68-A-168-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-69-A-069-A R6764-69-A-069-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6764-69-A-069-B R6764-69-A-069-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6766-21-A-002-A R6766-21-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6768-11-A-001-A R6768-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6768-12-A-002-A R6768-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6771-22-A-003-A R6771-22-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6775-12-A-203-C R6775-12-A-203-C.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-11-A-001-A R6781-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-12-A-003-A R6781-12-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-13-A-006-A R6781-13-A-006-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-14-A-007-A R6781-14-A-007-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-21-A-002-A R6781-21-A-002-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-22-A-004A R6781-22-A-004A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-32-A-008-A R6781-32-A-008-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-33-A-001-A R6781-33-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6781-34-A-003-A R6781-34-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6785-18-A-091-B R6785-18-A-091-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6785-19-A-093-A R6785-19-A-093-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6785-21-A-028-A R6785-21-A-028-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6785-24-A-089-A R6785-24-A-089-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6785-25-A-090-A R6785-25-A-090-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6785-26-A-030-A R6785-26-A-030-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6789-22-A-022-A R6789-22-A-022-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6789-41-A-041-A R6789-41-A-041-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6789-44-A-044-A R6789-44-A-044-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6789-52-A-052-A R6789-52-A-052-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6790-22-A-022-A R6790-22-A-022-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6793-11-A-131-A R6793-11-A-131-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6793-12-A-222-A R6793-12-A-222-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6793-15-A-015-A R6793-15-A-015-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6793-17-A-017-A R6793-17-A-017-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6793-42-A-042-A R6793-42-A-042-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6795-11-A-111-A R6795-11-A-111-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6795-12-A-112-A R6795-12-A-112-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
R6797-40-A-040-A R6797-40-A-040-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------
-30-
R6797-55-A-055-A R6797-55-A-055-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-----------------------------------------------------------------------------------------
RF105-12-A-002-B RF105-12-A-002-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-----------------------------------------------------------------------------------------
RF109-12-A-001-A RF109-12-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-----------------------------------------------------------------------------------------
RF109-12-A-001-B RF109-12-A-001-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-----------------------------------------------------------------------------------------
RM501-14-A-003-A RM501-14-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-----------------------------------------------------------------------------------------
USR90-11-A-011-A USR90-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-----------------------------------------------------------------------------------------
USR90-12-A-012-A USR90-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-----------------------------------------------------------------------------------------
TEST COSTS
THIS COST INCLUDES LEADSCAN/BAKE/AND SHIPPING COST
* ALSO, THERE WILL BE AN ADDITIONAL CHARGE FOR TAPE AND REEL IF THERE IS A
REQUEST FOR A REPACK.
TEST COST >
PARTNAME PARTID (ROUNDED)
06815-25-A-002-A 06815-25-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06815-36-A-003-A 06815-36-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06827-14-A-024-A 06827-14-A-024-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06829-11-A-001-A 06829-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06830-16-A-010-A 06830-16-A-010-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06830-16-A-012-A 06830-16-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06831-12-A-002-A 06831-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06832-11-A-001-A 06832-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06832-12-A-002-A 06832-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06834-11-A-001-A 06834-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06834-12-A-002-A 06834-12-A-002-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06835-14-A-002-A 06835-14-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06835-25-A-001-A 06835-25-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06836-11-A-011-A 06836-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
06836-11-A-011-A 06836-11-A-011-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
07202-11-A-001-A 07202-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11235-14-A-003-A 11235-14-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11246-12-A-001-A 11246-12-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11247-11-A-011-A 11247-11-A-011-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11247-12-A-012-A 11247-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11252-11-A-011-A 11252-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11252-15-A-015-A 11252-15-A-015-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11473-12-A-001-A 11473-12-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11558-11-A-001-A 11558-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11562-11-A-001-A 11562-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11577-11-A-001-A 11577-11-A-001-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11596-21-A-002-A 11596-21-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11609-11-A-001-A 11609-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11614-71-A-013-A 11614-71-A-013-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11614-72-A-014-A 11614-72-A-014-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-31-
11614-81-A-015-A 11614-81-A-015-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11614-82-A-016-A 11614-82-A-016-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11623-20-A-005-A 11623-20-A-005-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11627-31-A-031-A 11627-31-A-031-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11634-11-A-001-A 11634-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11661-11-A-001-A 11661-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
20415-11-A-001-A 20415-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
20431-21-A-001-A 20431-21-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
20437-11-A-001-A 20437-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
20438-11-A-011-A 20438-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
20441-11-A-001-A 20441-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
20463-11-A-001-A 20463-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
20468-21-A-001-A 20468-21-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
24105-13-A-001-B 24105-13-A-001-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
24106-15-A-002-C 24106-15-A-002-C.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
24110-11-A-001-A 24110-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
24408-16-A-002-A 24408-16-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
24942-13-A-001-B 24942-13-A-001-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25459-13-A-002-BO 25459-13-A-002-BO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25473-12-A-001-A 25473-12-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25473-13-A-001-A 25473-13-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25827-14-A-004-B 25827-14-A-004-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25829-18-A-007-B 25829-18-A-007-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25835-14-A-004-A 25835-14-A-004-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25852-11-A-001-C 25852-11-A-001-C.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25860-14-A-002-A 25860-14-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25861-14-A-002-A 25861-14-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25864-19-A-005-A 25864-19-A-005-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25865-17-A-004-A 25865-17-A-004-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25865-17-A-004-B 25865-17-A-004-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25868-16-A-004-B 25868-16-A-004-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25868-16-A-004-B 25868-16-A-004-B.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25868-16-A-004-BO 25868-16-A-004-BO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25868-16-A-004-BO 25868-16-A-004-BO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25871-15-A-004-BO 25871-15-A-004-BO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
30988-11-A-001-A 30988-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
30991-13-A-002-A 30991-13-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
30999-11-A-001-A 30999-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31004-11-A-001-A 31004-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31005-11-A-001-A 31005-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31008-11-A-001-A 31008-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31010-11-A-001-A 31010-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31015-11-A-001-A 31015-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
88168-12-A-002-A 88168-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
C7504-12-A-012-A C7504-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
C7505-12-A-012-A C7505-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
C8103-13-A-002-A C8103-13-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-32-
D9450-13-A-002-A D9450-13-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
D9450-14-A-006-A D9450-14-A-006-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
D9450-15-A-001-A D9450-15-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L1902-11-A-011-A L1902-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L2701-12-A-002-A L2701-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L2701-15-A-005-A L2701-15-A-005-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L2702-12-A-002-A L2702-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L2702-15-A-005-A L2702-15-A-005-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L2800-38-A-001-A L2800-38-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L2800-40-A-001-A L2800-40-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L3903-54-A-162-A L3903-54-A-162-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
L5502-11-A-001-A L5502-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P2106-21-A-001-A P2106-21-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P2106-22-A-002-A P2106-22-A-002-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P2107-11-A-001-A P2107-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P4601-11-A-001-A P4601-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P5200-12-A-012-A P5200-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P5200-12-A-022-A P5200-12-A-022-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P8773-91-A-001-A P8773-91-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P9373-11-A-001-A P9373-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P9373-12-A-002-A P9373-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P9573-11-A-001-A P9573-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R1060-16-A-001-A R1060-16-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6522-33-A-001-A R6522-33-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6641-15-A-012B R6641-15-A-012B.05 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6642-25-A-009-A R6642-25-A-009-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6645-18-A-001-A R6645-18-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6653-12-A-001-B R6653-12-A-001-B.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6653-13-A-002-A R6653-13-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6653-15-A-004-A R6653-15-A-004-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6653-16-A-005-A R6653-16-A-005-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6653-20-A-009-A R6653-20-A-009-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6657-14-A-004-A R6657-14-A-004-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6657-16-A-007-A R6657-16-A-007-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6664-12-A-002-A R6664-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6675-58-A-030-A R6675-58-A-030-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6682-28-A-004-A R6682-28-A-004-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6686-11-A-001-A R6686-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6713-20-A-003-A R6713-20-A-003-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6713-22-A-004-A R6713-22-A-004-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6713-24-A-134-A R6713-24-A-134-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6713-26-A-135-A R6713-26-A-135-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6713-27-A-136-A R6713-27-A-136-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6713-29-A-138-A R6713-29-A-138-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6715-14-A-004-A R6715-14-A-004-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6719-11-A-019-A R6719-11-A-019-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6719-12-A-014-A R6719-12-A-014-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-33-
R6719-12-A-020-A R6719-12-A-020-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6732-13-A-002-AA R6732-13-A-002-AA.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6732-13-A-003-A R6732-13-A-003-A.04 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6753-14-A-014-A R6753-14-A-014-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6753-15-A-006-A R6753-15-A-006-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6753-50-A-050-A R6753-50-A-050-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6753-72-A-072-A R6753-72-A-072-A.04 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6753-85-A-085-A R6753-85-A-085-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6753-86-A-086-A R6753-86-A-086-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6758-13-A-003-A R6758-13-A-003-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6758-14-A-001-A R6758-14-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6758-15-A-002-A R6758-15-A-002-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6758-16-A-004-A R6758-16-A-004-A.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-21-A-121-A R6764-21-A-121-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-24-A-024-A R6764-24-A-024-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-26-A-126-A R6764-26-A-126-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-28-A-127-A R6764-28-A-127-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-29-A-029-A R6764-29-A-029-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-38-A-038-A R6764-38-A-038-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-61-A-261-B R6764-61-A-261-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-62-A-362-B R6764-62-A-362-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-63-A-263-A R6764-63-A-263-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-65-A-165-B R6764-65-A-165-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-67-A-167-A R6764-67-A-167-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-68-A-168-A R6764-68-A-168-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-69-A-069-A R6764-69-A-069-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6764-69-A-069-B R6764-69-A-069-B.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6766-21-A-002-A R6766-21-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6768-11-A-001-A R6768-11-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6768-12-A-002-A R6768-12-A-002-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6771-22-A-003-A R6771-22-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6775-12-A-203-C R6775-12-A-203-C.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6781-11-A-001-A R6781-11-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6781-12-A-003-A R6781-12-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6781-13-A-006-A R6781-13-A-006-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6781-14-A-007-A R6781-14-A-007-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6781-21-A-002-A R6781-21-A-002-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6781-32-A-008-A R6781-32-A-008-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6781-33-A-001-A R6781-33-A-001-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6781-34-A-003-A R6781-34-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6785-18-A-091-B R6785-18-A-091-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6785-19-A-093-A R6785-19-A-093-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6785-21-A-028-A R6785-21-A-028-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6785-24-A-089-A R6785-24-A-089-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6785-25-A-090-A R6785-25-A-090-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6785-26-A-030-A R6785-26-A-030-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6789-22-A-022-A R6789-22-A-022-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-34-
R6789-41-A-041-A R6789-41-A-041-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6789-44-A-044-A R6789-44-A-044-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6789-52-A-052-A R6789-52-A-052-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6790-22-A-022-A R6790-22-A-022-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6793-11-A-131-A R6793-11-A-131-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6793-12-A-222-A R6793-12-A-222-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6793-15-A-015-A R6793-15-A-015-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6793-17-A-017-A R6793-17-A-017-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6793-42-A-042-A R6793-42-A-042-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6795-11-A-111-A R6795-11-A-111-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6795-12-A-112-A R6795-12-A-112-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6797-40-A-040-A R6797-40-A-040-A.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6797-55-A-055-A R6797-55-A-055-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
RF105-12-A-002-B RF105-12-A-002-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
RF109-12-A-001-A RF109-12-A-001-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
RF109-12-A-001-B RF109-12-A-001-B.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
RM501-14-A-003-A RM501-14-A-003-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
USR90-11-A-011-A USR90-11-A-011-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
USR90-12-A-012-A USR90-12-A-012-A.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
10485-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11239-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11242-11-A-011-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11552-13-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11572-11-A-101-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11573-12-A-003-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
11577-12-A-002-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
24106-16-A-003-AO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
24108-20ES-A-013-AO.04 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25121-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25218-12-A-002-AO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25252-11-A-001-AO.03 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25254-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25261-11-A-001-AO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25458-13-A-002-AO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25458-14-A-002-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25481-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25485-13-A-002-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25485-14-A-002-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25497-13-A-002-BO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25498-12-A-001-CO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25498-14-A-002-BO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25858-11-A-001-BO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25866-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
25869-16-A-004-CO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31001-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31003-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31006-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-35-
31006-12-A-002-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31009-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
31023-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P2106-23-A-003-AO.02 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P5100-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
P5200-14-A-014-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
R6744-11-A-001-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
RF110-12-A-002-AO.01 [CONFIDENTIAL TREATMENT REQUESTED]/*/
MINDSPEED ASSEMBLY AND TEST COST
MINDSPEED PART SKYWORKS SAP TEST PART ASSY COST TEST COST-MEX
J20462-14P-001AT [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J20464-12P-001AT J20464-12P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J20464-13P-001AT [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J20464-15P-004AT J20464-15P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J20472-12P-001AT J20472-12P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J20501-12P-002AT J20501-12P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28110-12-001AT J28110-12-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28235-15-003AT J28235-15-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28250-23ES-004AT J28250-23ES-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28300-12-001AT J28300-12-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28330-13-002AT J28330-13-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28331-18-005AT J28331-18-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28332-15-001BT J28332-15-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28332-18-005AT J28332-18-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28333-18-006AT [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28333-34-005AT J28333-34-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28346-12-003AT J28346-12-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28348-12-003AT J28348-12-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28360-12-001AT J28360-12-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28365-13-001AT J28365-13-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28398-25-007AT J28398-25-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28398-27-009AT J28398-27-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28471-16-001AT J28471-16-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28472-16-005BT J28472-16-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28475-17-003AT J28475-17-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28475-18-004AT J28475-18-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28476-17-003AT J28476-17-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28476-18-004AT J28476-18-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28477-17-003AT J28477-17-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28477-17R-003AT J28477-17R-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28477-18-004AT J28477-18-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28478-17-003AT J28478-17-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28478-17R-003AT J28478-17R-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28478-18-004AT J28478-18-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28510-14-001AT J28510-14-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
-36-
J28920-13-002AAT J28920-13-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28945-13-001AT J28945-13-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28945-13-002AT [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28945-33-001AT J28945-33-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28945-33-002AT [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28953-17-001BT [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28953-19-003BT J28953-19-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28970-14-003AT J28970-14-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J60083-15-002AT J60083-15-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J60083-15P-002AT J60083-15P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J60083-15P-AT [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J80310-11R-001AT J80310-11R-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J80310-11R-001AT2 [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JM28331-34-004AT JM28331-34-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JM28332-34-004AT JM28332-34-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JM28333-34-005AT JM28333-34-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JR1905-2P-001AT JR1905-2P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JR7181-38-008AT JR7181-38-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J60077-11-AT J60077-11-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J11952-22-001A J11952-22-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J20462-13P-001AO J20462-13P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J20462-14P-001AO J20462-14P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J20464-13P-001AO J20464-13P-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28234-13-005B J28234-13-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28342-11-002A J28342-11-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28343-11-002A J28343-11-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28344-11-002A J28344-11-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28344-11ES-002A J28344-11ES-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28370-22-008A J28370-22-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28370-23-008A J28370-23-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28375-16-004E J28375-16-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28376-16-004D J28376-16-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28392-25-002A J28392-25-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28394-17-001A J28394-17-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28394-25-003A J28394-25-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28395-25-002A J28395-25-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28395-26-002A J28395-26-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28398-26-008A J28398-26-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28952-11-001A J28952-11-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28952-12-001A J28952-12-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28953-17-001B J28953-17-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28953-17-001BP [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28953-18-002B J28953-18-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28954-13-002A J28954-13-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
J28956-21-004B J28956-21-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JL8565-16-006A JL8565-16-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JR6707-11-001A JR6707-11-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
-37-
JR6786-24-004A JR6786-24-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JR7132-16-002A JR7132-16-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
JR7133-28-006A JR7133-28-MTEST [CONFIDENTIAL TREATMENT REQUESTED]/*/ [CONFIDENTIAL TREATMENT REQUESTED]/*/
-38-
CONEXANT UNIQUE MATERIALS
--------------------------------------------------------------------------------------------------------------------------------
SAP
PART NUMBER CATEGORY ITEM TYPE DESCRIPTION STD / PRICE
--------------------------------------------------------------------------------------------------------------------------------
19032M02-005 Unique Epoxy Broadband SYRINGE/500GR [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
19032M02-009 Unique Epoxy Broadband EPOXY D/A TQFP CRM1079B [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
19032M02-01 Unique Epoxy Broadband D/A 84-1LMIS 36GR/SRY [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
19032M02-013 Unique Epoxy Broadband EPOXY D/A HYP TE-111-6R5 15G/S [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
19032V02-027 Unique Epoxy Broadband D/A EPOXY 8361J 36GR/SRY [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D139-003 Unique Leadframes Broadband 40PD1-N2- 200X200 R65,11473,5 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D140-005 Unique Leadframes Broadband X-40PD1-N4- 210X230 11471 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D140-007 Unique Leadframes Broadband x 40PD1-N6- 260X266 11476,R151 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D150-031 Unique Leadframes Broadband 64QU1-W4- 320X310 11951,41,R1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D163-005 Unique Leadframes Broadband 68PL1-Y2,Y4-300X300 (-011) C [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D163-007 Unique Leadframes Broadband 68PL1-Y5- 260X260(-021)28952, [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D163-009 Unique Leadframes Broadband X-68PL1-YE- 430X430 L8565 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D204-031 Unique Leadframes Broadband X-64QU2-WI- DUAL R6636-11 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D206-021 Unique Leadframes Broadband X-84PL1-43- 360X360 25458, 115 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D206-031 Unique Leadframes Broadband x84PL1-44- 400X400 11490-17,11 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D206-041 Unique Leadframes Broadband 84PL1-45- 275X275 C2900,L3903 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D209-001 Unique Leadframes Broadband 68PL2-Y6- DUAL R6622,41,R6781 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D217-001 Unique Leadframes Broadband x84HYP3-40- HYPAC R6741,42,61, [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D219-001 Unique Leadframes Broadband X-68PL2-Y0- DUAL R6638-12 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D219-003 Unique Leadframes Broadband X-68PL2-YF- DUAL R6715-13 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D224-001 Unique Leadframes Broadband 68PL2-YA- DUAL R6653,42 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D229-001 Unique Leadframes Broadband X-80PQ1-51- 320X320 L7905,11 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D229-005 Unique Leadframes Broadband 80PQ1-55- 260X260 L26,L39,258 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D229-007 Unique Leadframes Broadband X-80PQ1-57- 370X370 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D229-011 Unique Leadframes Broadband 80PQ1-CX11646-11 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D232-001 Unique Leadframes Broadband 100PQ2-1A- DUAL R6657/64/86 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D238-001 Unique Leadframes Broadband 68HYP2-2A- R6682, R6713,49,67 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D238-003 Unique Leadframes Broadband 68HYP2-2A R6713,49,67 HYPAC [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D241-003 Unique Leadframes Broadband 100PQ1-1D- 275X275 25827,24108 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D243-001 Unique Leadframes Broadband 100PQ2-1B- DUAL R6673,83 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D246-001 Unique Leadframes Broadband X-100PQ2-1F- DUAL R6646 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D251-001 Unique Leadframes Broadband 144TQ1-4A- 310X310 C75,C73,116 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D251-007 Unique Leadframes Broadband 144TQ1-4D- 350X350 11661,561, [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D283-001 Unique Leadframes Broadband 32TQ1-8A- 10497,25832,52,RF10 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D269-001 Unique Leadframes Broadband 128TQ1-BA- 360X360 L19XX,L27XX [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D269-005 Unique Leadframes Broadband 128TQ1-BC- 401X504 P2106-XX [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D269-009 Unique Leadframes Broadband x128TQ1-BJ- 6X6mm [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D272-001 Unique Leadframes Broadband 100PQ2-1J- DUAL R6675,31 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D274-003 Unique Leadframes Broadband 80PQ2-52- DUAL R6732-13 GaAs [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D286-001 Unique Leadframes Broadband 48TQ1-PA- 180x180 RF100 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D286-013 Unique Leadframes Broadband 48TQ1-PH- 3.5x3.5 24105-12.1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D286-015 Unique Leadframes Broadband 48TQ1-3.302x3.302 11634-11 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D290-003 Unique Leadframes Broadband X-100PQ2-1L- DUAL R6714 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D291-001 Unique Leadframes Broadband X-144TQ2-4J- DUAL [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D355-003 Unique Leadframes Broadband 52PQ1-K4- 25865 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D357-001 Unique Leadframes Broadband 144TQ2-4K- DUAL R6775,76,85 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D357-003 Unique Leadframes Broadband 144TQ2-4P- DUAL R6785 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D363-003 Unique Leadframes Broadband 176TQ1-4Y- 8X8mm 11229 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D363-009 Unique Leadframes Broadband 176T81-4X- 6x6 (11235/11236) [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D363-013 Unique Leadframes Broadband 176TQ1-4S- 10x10 (P4900-11) [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D445-001 Unique Leadframes Broadband X-144TQ2-4L- DUAL R6766 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D451-003 Unique Leadframes Broadband 64TQ1-W10- TQFP -20424-riptid [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D455-001 Unique Leadframes Broadband 100PQ2-1W- DUAL R6753 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D455-003 Unique Leadframes Broadband x 100PQ2-1N- DUAL R6815-11 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D457-001 Unique Leadframes Broadband 100PQ2-1Y- DUAL R6764,89 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D457-003 Unique Leadframes Broadband 100PQ2-1Z- DUAL R6719 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D457-005 Unique Leadframes Broadband 100PQ2-9D- (CX06832-12) [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D459-001 Unique Leadframes Broadband 128TQ2-BG- DUAL R6758 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D463-003 Unique Leadframes Broadband 144T82-4N- DUAL R6793,94 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D463-005 Unique Leadframes Broadband 144T82-4R- DUAL r6795-11,12 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D463-007 Unique Leadframes Broadband x144T82-xx- DUAL new from -00 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D463-009 Unique Leadframes Broadband 144LQFP-4G-Mono (CX06834-11 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D463-011 Unique Leadframes Broadband 144LQFP-4AA- Mono (CX06834-1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D477-003 Unique Leadframes Broadband 128TQ2-BK- DUAL 80m R6819-11-S [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D531-001 Unique Leadframes Broadband 100TQ1-9L- vTQFP 7.7x7.7mm [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D531-003 Unique Leadframes Broadband 100TQ1-9N- VTQFP (14 X 14X1mm) [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D531-003-S Unique Leadframes Broadband 100VTQFP Stamped (14 X 14X1mm) [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D531-005 Unique Leadframes Broadband 100TQ1-CX82500- VTQFP (14 X 14 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D591-001 Unique Leadframes Broadband 144LQ1-4AC- 3.440X3.4mm CX068 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D591-003 Unique Leadframes Broadband 144LQ1-CX06833-XX [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
GP00-D635-001 Unique Leadframes Broadband 128LQ1 CX80900-11 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------------------------------------------------------
-39-
CONEXANT UNIQUE MATERIALS - CONTINUED
---------------------------------------------------------------------------------------------------------------------------------
SAP
PART NUMBER CATEGORY ITEM TYPE DESCRIPTION STD / PRICE
---------------------------------------------------------------------------------------------------------------------------------
GP00-D689-001 Unique Leadframes Broadband 176LQFP-4ZA- (CX06835-25) [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
GP00-D691-001 Unique Leadframes Broadband 100TQ2-9J- (CX06836-11) [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-002A Unique Molding Compound Broadband 6300HG 55mmX98g 40L/64L/68L/ [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-002B Unique Molding Compound Broadband 6300HG 14mmX3.5g B0L/100L [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-002C Unique Molding Compound Broadband 6300HG 55mmX75g 40L/64L/68L/8 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-003A Unique Molding Compound Broadband 6300HJ 18mmX9.5g 68L TOWA [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-003B Unique Molding Compound Broadband 6300HJ 14mmX6.1g 100L TOWA [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-013B Unique Molding Compound Broadband 6650E 55mmX 104g 40L DIP/64L [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-013C Unique Molding Compound Broadband 6650E 14mmX3.7g 80L/100L (Man [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-020C Unique Molding Compound Broadband x7720HB 14X6.7g LGA 6x6(.16g) [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-013A Unique Molding Compound Broadband 6650E 18MMX10GR. (68L TOWA) [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR00-D609-003 Unique PCB's Broadband X- BOARD 84 LEADS R6639 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR00-D613-003 Unique PCB's Broadband BOARD 68L, R6640/44/45 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR00-D623-001 Unique PCB's Broadband BOARD 68L, R6682/R6684 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR01-D700-001 Unique PCB's Broadband BOARD 68L, R6695,97/R8725 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR01-D712-001 Unique PCB's Broadband BOARD 68L, R6735,36 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR02-D500-003 Unique PCB's Broadband BOARD 68L, R675,46,49,50,59,60 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR02-D506-001 Unique PCB's Broadband BOARD 68L, R6713, R6717 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR02-D513-001 Unique PCB's Broadband BOARD 68L, R6767 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR02-D514-001 Unique PCB's Broadband X-BOARD 68L, R6769,70,79,80 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR02-D515-001 Unique PCB's Broadband X-BOARD 84 LEADS R6761,R6762 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR02-D516-001 Unique PCB's Broadband BOARD 84 LEADS R6751,52 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
TR02-D545-001 Unique PCB's Broadband HYPAC BOARD 84L [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
COMMON MATERIAL
---------------------------------------------------------------------------------------------------------------------------------
SAP
PART NUMBER CATEGORY ITEM TYPE DESCRIPTION STD / PRICE
---------------------------------------------------------------------------------------------------------------------------------
19014M11-19 Common Gold Wire Shared GOLD WIRE 1.25MILS NORMAL [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19014M11-21 Common Gold Wire Shared GOLD WIRE 1.2MILS LOW LOOP [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19014M11-21-DC Common Gold Wire Shared GOLD WIRE 1.2MILS LOW LOOP - 3 [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-011A Common Molding Compound Shared 7351LS 14mmX5.5g 176(2.75g) [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-011B Common Molding Compound Shared 7351LS 14mmX3.9g 144L/48L/32L [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
19098V89-013D Common Molding Compound Shared 6650E 14mmX6.5g 100L (Auto Mo [CONFIDENTIAL TREATMENT
REQUESTED]/*/
---------------------------------------------------------------------------------------------------------------------------------
-40-
MINDSPEED RAW MATERIAL COSTS
SAP
PART NUMBER CATEGORY ITEM TYPE DESCRIPTION STD/PRICE
GP00-D456-001 Unique Leadframes Mindspeed 100PQ2-1X-DUAL R6786 [CONFIDENTIAL TREATMENT REQUESTED]/*/
GP00-D547-003 Unique Leadframes Mindspeed 144 ETQ2-4H-(Topaz) 28342-43/4 [CONFIDENTIAL TREATMENT REQUESTED]/*/
Molding
19098V89-007B Unique Compound Mindspeed 6710 48mmX80g 20L/24L (GaAs MA [CONFIDENTIAL TREATMENT REQUESTED]/*/
Molding 7720HL 14mmX4.1g BGA 27mm
19098V89-012A Unique Compound Mindspeed TOWA [CONFIDENTIAL TREATMENT REQUESTED]/*/
Molding 7720HL 14mmX5.7g BGA 35mm
19098V89-012B Unique Compound Mindspeed TOWA [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D111-001 Unique PCB's Mindspeed X-BGA BOARD 144L R7 130 [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D116-001 Unique PCB's Mindspeed X-BGA BOARD [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D118-001 Unique PCB's Mindspeed X-BGA BOARD [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D138-001 Unique PCB's Mindspeed BGA BOARD 268L R7133-28 [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D146-001 Unique PCB's Mindspeed BGA BOARD 268L [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D149-001 Unique PCB's Mindspeed X-340 BGA Board XXXX/6(M23/P88 [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D151-001 Unique PCB's Mindspeed X-BGA BOARD 340L R7138 [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D158-001 Unique PCB's Mindspeed X-BGA BOARD 268L [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D161-001 Unique PCB's Mindspeed xBGA BOARD (TRIPAC) R7177, R71 [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D168-001 Unique PCB's Mindspeed BGA BOARD 400 (DDP/8 CSM K56) [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D174-001 Unique PCB's Mindspeed X-BGA BOARD 318L 27mm (use D1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D176-003 Unique PCB's Mindspeed BGA BOARD 318L 27mm (Replace" [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D179-001 Unique PCB's Mindspeed 340 BGA Board XXXX (M24/P94) R [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D182-001 Unique PCB's Mindspeed X-R7155 BGA BOARD [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D183-001 Unique PCB's Mindspeed BGA BOARD 256L 27mm (Peak-7) R [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D191-001 Unique PCB's Mindspeed X-BGA BOARD (TRIPAC) R7178, [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D306-001 Unique PCB's Mindspeed BGA BOARD 388L [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D485-001 Unique PCB's Mindspeed X-BGA BOARD 272L [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D485-003 Unique PCB's Mindspeed BGA BOARD 272L 28228-11, 16 [CONFIDENTIAL TREATMENT REQUESTED]/*/
BGA BOARD 388L 35mm
TR03-D525-003 Unique PCB's Mindspeed (28234/282 [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D605-001 Unique PCB's Mindspeed BGA BOARD 264L 27MM (4 Layer) [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D655-001 Unique PCB's Mindspeed X-340 BGA CSM6V M24/P96 R7181 [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D885-001 Unique PCB's Mindspeed BGA BOARD 264L 27MM (4 Layer) [CONFIDENTIAL TREATMENT REQUESTED]/*/
TR03-D905-001 Unique PCB's Mindspeed BGA BOARD, 27MM - (MFC2000; P [CONFIDENTIAL TREATMENT REQUESTED]/*/
-41-
PROTOTYPE ASSEMBLY CHARGES (NOT INCLUDING LABOR)
PROTOTYPE PRICING:
The prototype charge consist of three parts; a flat per lot charge of $350, a
per unit charge, and a material cost charge. The prototype pricing per unit
charge starts with the same standard cost or purchase order price subtracting
any labor costs. These prices are shown in this Exhibit B. At the end of the
month the labor cost per unit is calculated by taking the total labor costs and
dividing by the number of prototype units. The per unit labor charge is then
added to the per unit charge shown in this Exhibit B. The material is charged
based on the amount and cost removed from the stockroom. For the test charge,
the standard cost per platform is used as shown in Exhibit F.
---------------------------------------------------------------------------------
PROTOTYPE
PACKAGE COST
YIELDED WITH OUT
PACKAGE CODE PACKAGE TYPE LABOR (OH)
---------------------------------------------------------------------------------
020TQ1 20L TQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
024TQ1 24L PQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
032TQ1 32L LQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
048TQ1 48L LQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
040PD1 40L DIP [CONFIDENTIAL TREATMENT REQUESTED]/*/
064TQ1 64L LQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
064QU1 64L QUIP [CONFIDENTIAL TREATMENT REQUESTED]/*/
064QU2 64L Monopac [CONFIDENTIAL TREATMENT REQUESTED]/*/
068PL1 68L PLCC [CONFIDENTIAL TREATMENT REQUESTED]/*/
068PL2 68L Monopac [CONFIDENTIAL TREATMENT REQUESTED]/*/
084PL1 84L PLCC [CONFIDENTIAL TREATMENT REQUESTED]/*/
068HY3 68L Hypac 3 die [CONFIDENTIAL TREATMENT REQUESTED]/*/
068HY4 68L Hypac 4 die [CONFIDENTIAL TREATMENT REQUESTED]/*/
084HY3 84L Hypac 3 die [CONFIDENTIAL TREATMENT REQUESTED]/*/
052PQ1 52L PQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
080PQ1 80L PQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
080PQ2 80L Monopac [CONFIDENTIAL TREATMENT REQUESTED]/*/
100TQ1 100L TQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
100PQ1 100L PQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
100PQ2 100L Monopac [CONFIDENTIAL TREATMENT REQUESTED]/*/
128TQ1 128L LQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
128TQ2 128L LQFP Mono [CONFIDENTIAL TREATMENT REQUESTED]/*/
128T81 128L LQ 80 Micron [CONFIDENTIAL TREATMENT REQUESTED]/*/
144TQ1 144L LQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
144TQ2 144L LQ Monopac [CONFIDENTIAL TREATMENT REQUESTED]/*/
144T82 144L LQ 80 Micron [CONFIDENTIAL TREATMENT REQUESTED]/*/
176TQ1 176L LQFP [CONFIDENTIAL TREATMENT REQUESTED]/*/
176T81 176L LQ 80 Micron [CONFIDENTIAL TREATMENT REQUESTED]/*/
---------------------------------------------------------------------------------
42
EXHIBIT C - MANUFACTURING SERVICES
1. All Services will be provided to Buyer by Supplier in accordance with
specifications provided by Buyer and in accordance with Supplier Manufacturing
Operating Procedures.
2. Manufacturing Services will include assembly, final testing, and
post-test processing of Devices produced by Supplier manufacturing facility
of the type provided by Buyer prior to the Effective Date.
3. Engineering Activities and Test Boards.
a. Buyer will be responsible for its own packaging engineering
activities, including design form, fit, and function.
b. First article final test interface boards and handler kits are
to be provided by Buyer within thirty (30) days of release of a new Device.
Complete drawings and specifications are to be provided by Buyer to Supplier
prior to the release of hardware to Supplier for testing.
4. Finished Goods Inventory Storage. The Services will include storage of
Buyer's product, which was manufactured at a Supplier facility, until such time
as Buyer directs Supplier to ship the Products. Finished goods inventory shall
be limited to invoiced and built deliverables, and shall be transferred to Buyer
upon the occurrence of either expiration or termination of this Agreement,
whichever is earlier. This finished goods inventory storage will be provided at
no charge to Buyer.
43
EXHIBIT D - QUALITY SPECIFICATIONS
00000X00 Xxxxxxxx Quality Manual
19592U09 Incoming inspection procedure
19592U12 Control and disposition of material and non-conforming material
19592U01 General process procedure
FGN5603 Receiving, packaging, and product storage into Finish Good
44
EXHIBIT E - PURCHASE COMMITMENTS
The take or pay commitments in spending in listed below for year 1. There is no
take or pay for Unique Material and Common Material. The take or pay is based on
the quarterly rates, shown in Exhibit F and activity shown in Exhibit G. The
take or pay is same as the planned absorption for the quarter for Buyer
(referred to in the table below as "CNXT").
---------------------------------------------------------------------------------------------------
Q4-02 Q1-03 Q2-03 Q3-03
---------------------------------------------------------------------------------------------------
CNXT Absorption [CONFIDENTIAL TREATMENT REQUESTED]/*/
Total Absorption [CONFIDENTIAL TREATMENT REQUESTED]/*/
---------------------------------------------------------------------------------------------------
45
EXHIBIT F - ASSEMBLY, TEST AND SHIPPING QUARTERLY RATES
QUARTERLY ASSEMBLY RATES
-------------------------------------------------------------------------------------------------------------------
Q4'02 PKG TYPE Q1'03 PKG TYPE Q2'03 PKG TYPE Q3'03 PKG TYPE STD. COST RATE
PACKAGE JULY-SEPT OCT-DEC JAN-MARCH APRIL-JUNE AVG. FOR YEAR
TYPES 2/4 SDF 2/4 SDF 2/4 SDF 2/4 SDF 2-4 SDF
-------------------------------------------------------------------------------------------------------------------
020TQ1
-------------------------------------------------------------------------------------------------------------------
024TQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
032TQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
048TQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
040PD1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
064TQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
064QU1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
064QU2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
068PL1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
068PL2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
084PL1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
068HY3 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
068HY4 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
084HY3 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
052PQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
080PQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
080PQ2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
100TQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
100PQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
100PQ2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
128TQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
128TQ2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
128T81 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
144TQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
144TQ2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
144T82 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
176TQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
176T81 [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
QUARTERLY TEST RATES
-------------------------------------------------------------------------------------------------------------------
X0-0 X0-00 X0-00 X0-00 XXX. COST RATE
JULY-SEPT OCT-DEC JAN-MARCH APRIL-JUNE AVG. FOR YEAR
PLATFORM ($/HR) ($/HR) ($/HR) ($/HR) ($/HR)
-------------------------------------------------------------------------------------------------------------------
LTX
-------------------------------------------------------------------------------------------------------------------
Trillium [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
Synchro [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
HP84K [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
Fast PA [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
Teradyne [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
Catalyst [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
System Test [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
Lead Scan
Cost/Unit [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
Bake and Shipping
Cost/Unit [CONFIDENTIAL TREATMENT REQUESTED]/*/
-------------------------------------------------------------------------------------------------------------------
46
EXHIBIT G - TAKE OR PAY ACTIVITY
--------------------------------------------------------------------------------
CONEXANT TAKE OR PAY ACTIVITY-ASSEMBLY
START PER DAY
PACKAGE TYPES Q4-02 Ql-03 Q2-03 Q3-03
--------------------------------------------------------------------------------
032TQl [CONFIDENTIAL TREATMENT REQUESTED]/*/
048TQl [CONFIDENTIAL TREATMENT REQUESTED]/*/
040PDl [CONFIDENTIAL TREATMENT REQUESTED]/*/
064TQl [CONFIDENTIAL TREATMENT REQUESTED]/*/
064QUl [CONFIDENTIAL TREATMENT REQUESTED]/*/
064QU2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
068PLl [CONFIDENTIAL TREATMENT REQUESTED]/*/
068PL2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
084PLl [CONFIDENTIAL TREATMENT REQUESTED]/*/
068HY3 [CONFIDENTIAL TREATMENT REQUESTED]/*/
068HY4 [CONFIDENTIAL TREATMENT REQUESTED]/*/
084HY3 [CONFIDENTIAL TREATMENT REQUESTED]/*/
052PQl [CONFIDENTIAL TREATMENT REQUESTED]/*/
080PQl [CONFIDENTIAL TREATMENT REQUESTED]/*/
080PQ2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
1OOTQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
1OOPQ1 [CONFIDENTIAL TREATMENT REQUESTED]/*/
1OOPQ2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
128TQl [CONFIDENTIAL TREATMENT REQUESTED]/*/
128TQ2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
128T81 [CONFIDENTIAL TREATMENT REQUESTED]/*/
144TQl [CONFIDENTIAL TREATMENT REQUESTED]/*/
144TQ2 [CONFIDENTIAL TREATMENT REQUESTED]/*/
144T82 [CONFIDENTIAL TREATMENT REQUESTED]/*/
176TQl [CONFIDENTIAL TREATMENT REQUESTED]/*/
176T81 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
QUARTERLY CONEXANT TEST TAKE OR PAY HOURS
--------------------------------------------------------------------------------
CONEXANT Q4-02 Q1-03 Q2-03 Q3-03
HOURS JULY-SEPT OCT-DEC JAN-MARCH APRIL-JUNE
PLATFORM ($/HR) ($/HR) ($/HR) ($/HR)
--------------------------------------------------------------------------------
LTX [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
Trillium [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
Synchro [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
HP84000 [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
Fast PA [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
Teradyne [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
Catalyst [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
System [CONFIDENTIAL TREATMENT REQUESTED]/*/
--------------------------------------------------------------------------------
47.
EXHIBIT H - [INTENTIONALLY LEFT BLANK]
-48-
EXHIBIT I - DELIVERY AND LOGISTICS
The Supplier will comply with any special shipping instructions specified on
Buyer's Purchase Orders.
1. The Supplier will receive Delivery Note or Reservation from Buyer's
Customer Logistics Group; the supplier will Pick and pack Delivery Note
according to document FGN5604, instructions and Guides for Packers.
2. The Supplier will Post Delivery Note and prepare US and Mexican Customs
paperwork on Buyer's SAP system. The supplier will transport goods to Mexican
Custom Brokers office for Mexican Export Pedimento preparation.
3. The Supplier will then transport goods to the US Custom Brokers local
office for US Customs Import Declaration preparation.
Additional shipping details are as follows:
(a) Shipping services shall include, (as specified by Buyer), tape and
reel handling and packaging for delivery in accordance with appropriate
packaging specifications provided by Buyer, box and hold, if specified)
preparing required shipping paperwork.
(b) Supplier shall be responsible for preparing and including in each
shipment the following shipping paperwork prepared on buyer's SAP system: airway
xxxx from freight forwarder export documentation customs clearance documentation
and packing list, barcode labeling, and any other paperwork agreed to by the
Parties. Supplier will also update all systems for Supplier and Buyer databases
as necessary to support the shipping function. This would include, but not be
limited to; Delivery Notes, reservations, scrap requests and all internal
systems such as SAP, Promis, Die Manager, and Pack-a-way and external systems as
FedEx, DHL, UPS, Xxxxx, etc., provided that Buyer will be responsible for
continued support for the following systems: Die Manager and Pack-a-way.
Supplier shall also, upon request, provide Buyer with information related to
shipment metrics, including, but not limited to: quantity of shipments, type of
shipments, etc.
(c) To the extent not otherwise specifically provided for in this
Exhibit I, the policies and procedures governing the shipping services provided
by Supplier to Buyer hereunder shall be consistent with those policies and
procedures set forth in Buyer's standard operating procedures (NPB SOP-0156) as
in effect immediately prior to the Effective Date. The Parties may negotiate in
good faith from time to time to revise such procedures as deemed necessary by
either of the Parties. In the event of any conflict between the terms of this
Agreement and such standard operating procedures, the terms of this Agreement
shall control. Buyer shall be responsible for obtaining all governmental
approvals, , and notifying Supplier of all procedures required for compliance
with any laws or regulations pertaining to the shipment or export of any
products or materials; provided, however, that Supplier shall be responsible for
confirming, prior to effecting any shipment, that such approvals, etc. have been
obtained.
-49-
EXHIBIT J - REPORTS
----------------------------------------------------------------------------------------------------------------
AREA REPORT DESCRIPTION CAPABILITY IN PLACE FREQUENCY FORMAT
----------------------------------------------------------------------------------------------------------------
Assembly End to end Assembly yield and
Pareto failures Yes Monthly Excel
-----------------------------------------------------------------------------------------------
Assembly yield by package type Yes Monthly Excel
-----------------------------------------------------------------------------------------------
Assembly Cycle time Yes Monthly Excel
-----------------------------------------------------------------------------------------------
Assembly Cycle time by package type Yes Monthly Excel
-----------------------------------------------------------------------------------------------
SMT Yield Yes Monthly Excel
----------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
Test/PE Overall Test yield and pareto failures Yes on Web Monthly Excel
-----------------------------------------------------------------------------------------------
Test yield by product type and pareto
failures Yes on Web Monthly Excel
-----------------------------------------------------------------------------------------------
Low yield lot disposition Yes on Web Monthly Excel
-----------------------------------------------------------------------------------------------
Electrical PPM by product Yes on Web Monthly Excel
-----------------------------------------------------------------------------------------------
Overall Test Cycle time Yes will be on Web Monthly Excel
-----------------------------------------------------------------------------------------------
Test Cycle time by package type Yes will be on Web Monthly Excel
----------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
QA Cpk on critical operations Yes Monthly Excel
-----------------------------------------------------------------------------------------------
Cpk on critical operations by package
type on going Monthly Excel
-----------------------------------------------------------------------------------------------
CAL test results yes Monthly Excel
-----------------------------------------------------------------------------------------------
3rd opticle inspection by package
type on going Monthly Excel
----------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
Product 13 Weeks commit report yes Monthly Excel
Control -----------------------------------------------------------------------------------------------
Web-
WIP status on going Real time base
----------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------
Mindspeed Material Die Consumption Report Yes Monthly Excel
Material Die
Consumption
----------------------------------------------------------------------------------------------------------------
-50-
EXHIBIT K - RECONCILIATION TABLE
------------------------------------------------------------------------------------------
ACTIVITY/ABSORPTION IMPACT
TO QUARTERLY PLAN TO
CNXT SKYWORKS RATES CONEXANT ACTION AND IMPACT
------------------------------------------------------------------------------------------
Flat Flat No Change Use Qtr. Planned Rates Qtr. Planned Take or Pay
------------------------------------------------------------------------------------------
Flat Up Decrease Use Actual Rates Better than Take or Pay
------------------------------------------------------------------------------------------
Flat Down Increase Use Qtr. Planned Rates Qtr. Planned Take or Pay
------------------------------------------------------------------------------------------
Down Flat Increase Use Qtr. Planned Rates Qtr. Planned Take or Pay
------------------------------------------------------------------------------------------
Down Up Increase Use Qtr. Planned Rates Qtr. Planned Take or Pay
---------------------------------------------------------------------
Decrease Use Actual Rates Better than Take or Pay
------------------------------------------------------------------------------------------
Down Down Increase Use Qtr. Planned Rates Qtr. Planned Take or Pay
------------------------------------------------------------------------------------------
UP Flat Decrease Use Actual Rates Better than Take or Pay
------------------------------------------------------------------------------------------
up Up Decrease Use Actual Rates Better than Take or Pay
------------------------------------------------------------------------------------------
UP Down Increase Use Qtr. Planned Rates Qtr. Planned Take or Pay
---------------------------------------------------------------------
Decrease Use Actual Rates Better than Take or Pay
------------------------------------------------------------------------------------------
51.
